,Var1,Metadata_moa.x,Metadata_Plate_Map_Name.x
0,BRD-A00100033-001-04-8,DNA inhibitor,H-BIOA-001-3
1,BRD-A00267231-001-01-1,Adenosine receptor agonist,H-BIOA-001-3
2,BRD-A00520476-001-03-3,Acetylcholine receptor antagonist,H-BIOA-001-3
3,BRD-A00993607-003-04-8,Adrenergic receptor antagonist,H-BIOA-001-3
4,BRD-A01078468-001-04-9,synthetic estrogen,H-BIOA-001-3
5,BRD-A01295252-001-01-5,Dopamine receptor ligand,H-BIOA-001-3
6,BRD-A01320529-001-05-9,adrenergic receptor agonist,H-BIOA-001-3
7,BRD-A01593789-001-01-5,5 alpha reductase inhibitor,H-BIOA-001-3
8,BRD-A01636364-003-04-5,sodium channel blocker,H-BIOA-001-3
9,BRD-A01787639-003-08-6,adrenergic receptor antagonist,H-BIOA-001-3
10,BRD-A02006392-001-06-5,calcium channel blocker,H-BIOA-001-3
11,BRD-A02176148-001-02-2,Mitochondrial complex I inhibitor,H-BIOA-001-3
12,BRD-A02710418-003-03-5,opioid receptor agonist,H-BIOA-001-3
13,BRD-A02713983-001-02-0,growth factor receptor activator,H-BIOA-001-3
14,BRD-A02759312-003-11-2,Adrenergic receptor antagonist,H-BIOA-001-3
15,BRD-A03216249-003-02-9,Potassium channel blocker,H-BIOA-001-3
16,BRD-A03359064-001-01-5,Adrenergic receptor antagonist,H-BIOA-001-3
17,BRD-A03623303-045-02-0,Adrenergic receptor antagonist,H-BIOA-001-3
18,BRD-A03816571-001-01-0,cannabinoid receptor agonist|CC chemokine receptor antagonist,H-BIOA-001-3
19,BRD-A04322457-003-03-9,adrenergic receptor agonist,H-BIOA-001-3
20,BRD-A04438777-001-01-4,dopamine receptor agonist,H-BIOA-001-3
21,BRD-A04553218-050-03-0,histamine receptor antagonist,H-BIOA-001-3
22,BRD-A04668240-001-01-5,GABA receptor antagonist,H-BIOA-001-3
23,BRD-A04706586-236-01-7,Adenosine receptor agonist,H-BIOA-001-3
24,BRD-A05186015-003-04-0,dopamine uptake inhibitor,H-BIOA-001-3
25,BRD-A06352418-001-03-6,Histamine receptor antagonist,H-BIOA-001-3
26,BRD-A06352508-001-02-9,CHK inhibitor,H-BIOA-001-3
27,BRD-A06390036-001-02-0,Antiarrhythmic,H-BIOA-001-3
28,BRD-A06726973-001-02-0,cGMP analog,H-BIOA-001-3
29,BRD-A06935312-001-02-7,bacterial 30S ribosomal subunit inhibitor,H-BIOA-001-3
30,BRD-A07207424-001-04-1,phosphodiesterase inhibitor,H-BIOA-001-3
31,BRD-A07440155-003-04-9,Adrenergic receptor antagonist,H-BIOA-001-3
32,BRD-A07780951-001-02-2,Adrenergic receptor agonist,H-BIOA-001-3
33,BRD-A07824748-001-02-6,11-beta hydroxysteroid dehydrogenase inhibitor,H-BIOA-001-3
34,BRD-A07875874-001-01-6,calcium channel blocker,H-BIOA-001-3
35,BRD-A07932845-001-01-1,anti-HCVE2,H-BIOA-001-3
36,BRD-A07952294-001-02-3,farnesyltransferase inhibitors,H-BIOA-001-3
37,BRD-A08187463-001-03-8,enkephalinase inhibitor,H-BIOA-001-3
38,BRD-A08709697-001-02-9,pyrrolizidine alkaloid,H-BIOA-001-3
39,BRD-A08877921-001-02-2,Protein synthesis inhibitor,H-BIOA-001-3
40,BRD-A09056319-003-03-6,Adrenergic receptor antagonist,H-BIOA-001-3
41,BRD-A09062839-003-03-5,Local anesthetic,H-BIOA-001-3
42,BRD-A09094913-001-02-3,acetylcholine receptor antagonist,H-BIOA-001-3
43,BRD-A09161221-001-01-9,HSP inhibitor,H-BIOA-001-3
44,BRD-A09349126-001-02-4,progesterone receptor agonist,H-BIOA-001-3
45,BRD-A09467419-003-04-2,acetylcholine receptor antagonist,H-BIOA-001-3
46,BRD-A09472452-001-02-8,Sodium channel blocker,H-BIOA-001-3
47,BRD-A09533288-001-02-7,calcium channel blocker,H-BIOA-001-3
48,BRD-A09539288-004-02-8,Acetylcholine receptor antagonist,H-BIOA-001-3
49,BRD-A09828896-004-04-5,Dopamine receptor agonist,H-BIOA-001-3
50,BRD-A09925278-003-03-1,Adrenergic receptor agonist,H-BIOA-001-3
51,BRD-A10070317-003-05-1,adrenergic receptor antagonist,H-BIOA-001-3
52,BRD-A10355991-003-01-8,Glutamate receptor antagonist,H-BIOA-001-3
53,BRD-A10715913-001-02-0,Dopamine receptor antagonist,H-BIOA-001-3
54,BRD-A10739734-003-01-5,adrenergic receptor antagonist,H-BIOA-001-3
55,BRD-A10903566-003-02-8,Adrenergic receptor antagonist,H-BIOA-001-3
56,BRD-A10969569-001-02-0,Plant alkaloid,H-BIOA-001-3
57,BRD-A10977446-001-04-8,Adrenergic receptor antagonist,H-BIOA-001-3
58,BRD-A11605036-001-03-2,GABA receptor antagonist,H-BIOA-001-3
59,BRD-A11609859-303-01-2,opioid receptor agonist,H-BIOA-001-3
60,BRD-A11678676-001-02-6,PI3K inhibitor,H-BIOA-001-3
61,BRD-A11813248-001-02-8,Potassium channel blocker,H-BIOA-001-3
62,BRD-A12016240-001-01-7,Serotonin receptor antagonist,H-BIOA-001-3
63,BRD-A13188892-066-03-3,Adrenergic receptor antagonist,H-BIOA-001-3
64,BRD-A13650332-236-03-9,Bacterial cell wall synthesis inhibitor,H-BIOA-001-3
65,BRD-A13946108-001-03-1,Cyclooxygenase inhibitor,H-BIOA-001-3
66,BRD-A14395271-001-01-5,Dopamine receptor antagonist,H-BIOA-001-3
67,BRD-A14566392-004-03-5,acetylcholine receptor antagonist,H-BIOA-001-3
68,BRD-A14574269-051-01-4,Acetylcholine receptor agonist,H-BIOA-001-3
69,BRD-A15034104-002-03-6,interleukin inhibitor,H-BIOA-001-3
70,BRD-A15070535-323-02-1,adenosine receptor agonist|cAMP stimulant,H-BIOA-001-3
71,BRD-A15415227-003-01-1,PPAR receptor agonist,H-BIOA-001-3
72,BRD-A15435692-003-01-5,sigma receptor antagonist|glutamate receptor antagonist|serotonin receptor agonist,H-BIOA-001-3
73,BRD-A15530910-001-01-3,adrenergic receptor antagonist|serotonin receptor antagonist,H-BIOA-001-3
74,BRD-A15914070-001-01-5,cytotoxic lipid peroxidation product,H-BIOA-001-3
75,BRD-A16332958-001-02-4,Adrenergic receptor agonist,H-BIOA-001-3
76,BRD-A16665823-008-03-3,Bacterial cell wall synthesis inhibitor,H-BIOA-001-3
77,BRD-A16694057-001-02-7,PPAR receptor antagonist,H-BIOA-001-3
78,BRD-A17065207-001-06-9,protein synthesis inhibitor,H-BIOA-001-3
79,BRD-A17428743-001-01-1,Serotonin receptor agonist,H-BIOA-001-3
80,BRD-A17453586-001-01-9,Serotonin receptor agonist,H-BIOA-001-3
81,BRD-A17535965-001-02-2,Acetylcholine receptor antagonist,H-BIOA-001-3
82,BRD-A17655518-001-02-0,Cyclooxygenase inhibitor,H-BIOA-001-3
83,BRD-A18043272-001-03-2,succinimide antiepileptic,H-BIOA-001-3
84,BRD-A18202423-001-01-6,Glutamate receptor antagonist,H-BIOA-001-3
85,BRD-A18497530-001-04-6,adenosine kinase inhibitor|nucleoside transporter inhibitor,H-BIOA-001-3
86,BRD-A18579359-001-03-1,Neural Wiskott-Aldrich syndrome protein inhibitor,H-BIOA-001-3
87,BRD-A18696154-003-11-9,adrenergic receptor antagonist,H-BIOA-001-3
88,BRD-A18763547-019-01-0,Cytochrome C release inhibitor,H-BIOA-001-3
89,BRD-A19053259-003-03-3,Anthelmintic,H-BIOA-001-3
90,BRD-A19195498-050-04-2,Norepinephrine reuptake inhibitor,H-BIOA-001-3
91,BRD-A19736161-310-01-3,Serotonin receptor antagonist,H-BIOA-001-3
92,BRD-A20239487-001-02-5,Adrenergic receptor antagonist,H-BIOA-001-3
93,BRD-A20348246-001-04-2,GABA receptor modulator,H-BIOA-001-3
94,BRD-A20968261-001-01-3,glutamate transporter inhibitor,H-BIOA-001-3
95,BRD-A21723284-066-01-7,Opioid receptor antagonist,H-BIOA-001-3
96,BRD-A21858158-001-04-5,Anthelmintic,H-BIOA-001-3
97,BRD-A22305049-003-04-5,gluconeogenesis inhibitor,H-BIOA-001-3
98,BRD-A22380646-001-01-5,ATPase inhibitor,H-BIOA-001-3
99,BRD-A22684332-003-02-3,adrenergic receptor agonist,H-BIOA-001-3
100,BRD-A22707317-001-02-5,GABA receptor modulator,H-BIOA-001-3
101,BRD-A22769835-300-03-2,Antihistamine,H-BIOA-001-3
102,BRD-A22783572-065-01-3,microtubule formation inhibitor|tubulin inhibitor|tubulin polymerisation inhibitor,H-BIOA-001-3
103,BRD-A22844106-001-04-7,Cyclooxygenase inhibitor,H-BIOA-001-3
104,BRD-A23034328-003-03-4,protein synthesis inhibitor,H-BIOA-001-3
105,BRD-A23072235-050-04-5,Histamine receptor antagonist,H-BIOA-001-3
106,BRD-A23226398-001-02-7,estrogen receptor agonist,H-BIOA-001-3
107,BRD-A23683907-334-01-0,serotonin receptor antagonist,H-BIOA-001-3
108,BRD-A23723433-001-01-2,tubulin inhibitor|microtubule stabilizing agent|microtubule stimulant|P glycoprotein inhibitor|taxane,H-BIOA-001-3
109,BRD-A24122750-001-01-1,GABA receptor antagonist,H-BIOA-001-3
110,BRD-A24191444-045-03-1,Adrenergic receptor antagonist,H-BIOA-001-3
111,BRD-A24228527-001-04-2,Bacterial DNA gyrase inhibitor,H-BIOA-001-3
112,BRD-A24514565-236-01-6,Vitamin K antagonist,H-BIOA-001-3
113,BRD-A24587114-066-03-5,adrenergic receptor agonist,H-BIOA-001-3
114,BRD-A24817035-001-04-7,central nervous system agent,H-BIOA-001-3
115,BRD-A25234499-001-04-3,glucocorticoid receptor antagonist,H-BIOA-001-3
116,BRD-A25775766-001-03-3,GABA receptor antagonist|TP53 activator,H-BIOA-001-3
117,BRD-A26032986-050-01-3,Calmodulin antagonist,H-BIOA-001-3
118,BRD-A26222320-001-02-6,protein synthesis inhibitor,H-BIOA-001-3
119,BRD-A26334849-001-02-1,Antiarrhythmic,H-BIOA-001-3
120,BRD-A26384407-001-04-6,Carbonic anhydrase inhibitor,H-BIOA-001-3
121,BRD-A26711594-001-02-7,calcium channel blocker,H-BIOA-001-3
122,BRD-A26845397-001-01-4,Adrenergic receptor antagonist,H-BIOA-001-3
123,BRD-A27143604-001-01-2,Estrogen receptor agonist,H-BIOA-001-3
124,BRD-A28318179-003-03-6,Nitric oxide synthase inhibitor,H-BIOA-001-3
125,BRD-A28856712-003-04-7,adrenergic receptor agonist,H-BIOA-001-3
126,BRD-A29260609-003-04-7,adrenergic receptor antagonist,H-BIOA-001-3
127,BRD-A29289453-001-02-1,platelet activating factor receptor antagonist,H-BIOA-001-3
128,BRD-A29322418-237-02-4,mineralocorticoid receptor antagonist,H-BIOA-001-3
129,BRD-A29426959-050-04-1,Histamine receptor antagonist,H-BIOA-001-3
130,BRD-A29437505-001-01-6,TLR agonist,H-BIOA-001-3
131,BRD-A29644307-050-04-8,Dopamine uptake inhibitor,H-BIOA-001-3
132,BRD-A29734509-011-02-9,Sodium channel blocker,H-BIOA-001-3
133,BRD-A30590053-003-01-1,Acetylcholine release enhancer,H-BIOA-001-3
134,BRD-A30655177-001-04-1,BTK inhibitor,H-BIOA-001-3
135,BRD-A30717181-001-02-7,glucocorticoid receptor agonist,H-BIOA-001-3
136,BRD-A30815329-001-03-0,Calcium channel blocker,H-BIOA-001-3
137,BRD-A31007383-001-01-0,Adenosine receptor agonist,H-BIOA-001-3
138,BRD-A31159102-001-01-9,Selective serotonin reuptake inhibitor (SSRI),H-BIOA-001-3
139,BRD-A31195449-004-01-9,Serotonin receptor agonist,H-BIOA-001-3
140,BRD-A31521121-001-04-1,Muscle relaxant,H-BIOA-001-3
141,BRD-A31575449-300-01-4,Adrenergic receptor antagonist,H-BIOA-001-3
142,BRD-A31800922-003-04-6,acetylcholine receptor antagonist,H-BIOA-001-3
143,BRD-A32164164-048-01-4,Acetylcholine receptor antagonist,H-BIOA-001-3
144,BRD-A32505112-001-02-8,angiotensin converting enzyme inhibitor,H-BIOA-001-3
145,BRD-A32673558-003-02-1,acetylcholine receptor agonist,H-BIOA-001-3
146,BRD-A32949107-001-01-7,calcium channel blocker,H-BIOA-001-3
147,BRD-A33168282-003-06-5,Adrenergic receptor antagonist,H-BIOA-001-3
148,BRD-A33447119-001-02-5,Anthelmintic,H-BIOA-001-3
149,BRD-A33711280-311-02-0,Acetylcholine receptor antagonist,H-BIOA-001-3
150,BRD-A34255068-001-04-8,phosphodiesterase inhibitor,H-BIOA-001-3
151,BRD-A34309505-001-08-5,benzodiazepine receptor agonist,H-BIOA-001-3
152,BRD-A34706053-003-01-9,Adrenergic receptor agonist,H-BIOA-001-3
153,BRD-A34751532-001-03-6,HSP inducer,H-BIOA-001-3
154,BRD-A34788695-003-04-5,bacterial 30S ribosomal subunit inhibitor,H-BIOA-001-3
155,BRD-A34806832-001-02-7,ATPase inhibitor,H-BIOA-001-3
156,BRD-A35033682-001-01-0,cytochrome P450 inhibitor,H-BIOA-001-3
157,BRD-A35338386-001-04-6,adenosine receptor agonist,H-BIOA-001-3
158,BRD-A35511923-019-01-6,Somatostatin receptor agonist,H-BIOA-001-3
159,BRD-A35623999-001-03-2,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,H-BIOA-001-3
160,BRD-A35931254-003-02-7,dopamine receptor agonist,H-BIOA-001-3
161,BRD-A36066264-001-02-3,Estrogen receptor agonist,H-BIOA-001-3
162,BRD-A36074203-003-03-5,Glutamate receptor antagonist,H-BIOA-001-3
163,BRD-A36217750-001-04-9,Uricosuric blocker,H-BIOA-001-3
164,BRD-A36267905-003-02-8,Adrenergic receptor agonist,H-BIOA-001-3
165,BRD-A36318220-001-01-3,RIPK inhibitor,H-BIOA-001-3
166,BRD-A36471396-003-02-2,Acetylcholine receptor antagonist,H-BIOA-001-3
167,BRD-A37347161-003-01-8,opioid receptor agonist,H-BIOA-001-3
168,BRD-A37432947-004-02-5,acetylcholine receptor antagonist,H-BIOA-001-3
169,BRD-A37441042-003-02-2,adrenergic receptor agonist,H-BIOA-001-3
170,BRD-A37492983-001-03-8,radiopaque medium,H-BIOA-001-3
171,BRD-A37704979-001-02-4,p38 MAPK inhibitor,H-BIOA-001-3
172,BRD-A37776212-003-02-5,opioid receptor agonist,H-BIOA-001-3
173,BRD-A38747044-001-01-5,Imidazoline receptor ligand,H-BIOA-001-3
174,BRD-A38898897-003-01-0,Leukocyte elastase inhibitor,H-BIOA-001-3
175,BRD-A38913120-001-01-0,BCL inhibitor,H-BIOA-001-3
176,BRD-A39230911-001-03-7,Muscle relaxant,H-BIOA-001-3
177,BRD-A39255369-001-01-5,Chloride channel blocker,H-BIOA-001-3
178,BRD-A39268308-001-02-0,Acetylcholine receptor agonist,H-BIOA-001-3
179,BRD-A39522003-001-01-0,FAAH inhibitor|FAAH reuptake inhibitor,H-BIOA-001-3
180,BRD-A39747742-001-02-7,estrogen receptor agonist,H-BIOA-001-3
181,BRD-A39969961-001-01-3,Cytochrome P450 inhibitor,H-BIOA-001-3
182,BRD-A40022950-001-02-9,ATPase inhibitor,H-BIOA-001-3
183,BRD-A40639672-234-04-0,Cyclooxygenase inhibitor,H-BIOA-001-3
184,BRD-A41112154-001-02-1,G protein-coupled receptor agonist,H-BIOA-001-3
185,BRD-A41145729-001-02-7,Retinoid receptor agonist,H-BIOA-001-3
186,BRD-A41250306-001-03-4,Thiazide diuretic,H-BIOA-001-3
187,BRD-A41301928-001-02-5,"Mitochondrial ADP, ATP translocase inhibitor",H-BIOA-001-3
188,BRD-A41304429-001-04-9,Adrenergic receptor antagonist,H-BIOA-001-3
189,BRD-A41451487-001-01-3,Benzodiazepine receptor antagonist,H-BIOA-001-3
190,BRD-A41519720-001-02-2,Niemann-Pick C1-like 1 protein antagonist,H-BIOA-001-3
191,BRD-A41722204-003-01-5,adenosine receptor antagonist,H-BIOA-001-3
192,BRD-A41833852-001-01-9,Opioid receptor antagonist,H-BIOA-001-3
193,BRD-A41941932-001-03-0,Antioxidant,H-BIOA-001-3
194,BRD-A42167015-003-03-7,Adrenergic receptor antagonist,H-BIOA-001-3
195,BRD-A42335949-300-04-9,phosphatidylglycerophosphatase inhibitor,H-BIOA-001-3
196,BRD-A42346008-003-03-6,epinephrine metabolite,H-BIOA-001-3
197,BRD-A42553870-001-05-1,neuropeptide receptor antagonist,H-BIOA-001-3
198,BRD-A42571354-300-01-3,histamine receptor antagonist,H-BIOA-001-3
199,BRD-A42628519-001-04-1,radiopaque medium,H-BIOA-001-3
200,BRD-A42759514-001-03-1,Antiprotozoal,H-BIOA-001-3
201,BRD-A42831637-001-02-2,anti-inflammatory|Cannabinoid metabolite,H-BIOA-001-3
202,BRD-A43076080-001-03-3,protein phosphatase inhibitor,H-BIOA-001-3
203,BRD-A43150328-001-02-0,other antibiotic,H-BIOA-001-3
204,BRD-A43671941-003-03-6,Adrenergic receptor antagonist,H-BIOA-001-3
205,BRD-A43849199-001-02-3,Phytotoxin,H-BIOA-001-3
206,BRD-A43930669-003-01-0,oxytocin receptor antagonist,H-BIOA-001-3
207,BRD-A43940795-001-02-8,serotonin release inhibitor,H-BIOA-001-3
208,BRD-A43974499-066-01-1,Adrenergic receptor antagonist,H-BIOA-001-3
209,BRD-A44008656-036-04-3,Histamine receptor antagonist,H-BIOA-001-3
210,BRD-A44090213-001-04-1,Cyclooxygenase inhibitor,H-BIOA-001-3
211,BRD-A44133049-001-01-5,Serotonin receptor antagonist,H-BIOA-001-3
212,BRD-A44448661-001-02-2,Barbiturate antiepileptic,H-BIOA-001-3
213,BRD-A44551378-001-01-9,EGFR inhibitor,H-BIOA-001-3
214,BRD-A44863528-001-04-1,CCK receptor antagonist,H-BIOA-001-3
215,BRD-A44966919-001-03-1,acetylcholine receptor antagonist,H-BIOA-002-3
216,BRD-A45140972-060-02-4,bacterial 50S ribosomal subunit inhibitor,H-BIOA-002-3
217,BRD-A45499626-001-01-0,Glutamate receptor antagonist,H-BIOA-002-3
218,BRD-A45543382-001-02-7,radiopaque medium,H-BIOA-002-3
219,BRD-A46066006-004-04-4,muscarinic antagonist,H-BIOA-002-3
220,BRD-A47144777-001-02-5,HSP90 inhibitor,H-BIOA-002-3
221,BRD-A47494775-003-03-0,Adrenergic receptor agonist,H-BIOA-002-3
222,BRD-A47513740-001-02-5,protein phosphatase inhibitor,H-BIOA-002-3
223,BRD-A47598013-004-02-0,selective serotonin reuptake inhibitor (SSRI),H-BIOA-002-3
224,BRD-A47633927-001-01-8,ICAM1 antagonist,H-BIOA-006-3
225,BRD-A48257147-001-01-9,glutamate receptor agonist,H-BIOA-002-3
226,BRD-A48300215-001-01-4,sodium channel blocker,H-BIOA-002-3
227,BRD-A48809242-001-02-9,adenosine receptor agonist,H-BIOA-002-3
228,BRD-A49046702-001-01-2,GABA uptake inhibitor,H-BIOA-002-3
229,BRD-A49172652-001-13-1,ATPase inhibitor,H-BIOA-002-3
230,BRD-A49225603-045-02-7,histamine receptor agonist,H-BIOA-002-3
231,BRD-A49358627-001-03-9,PPAR receptor agonist,H-BIOA-002-3
232,BRD-A49370193-051-01-7,serotonin receptor agonist,H-BIOA-002-3
233,BRD-A49680073-001-01-9,JAK inhibitor|Lipocortin synthesis stimulant|STAT inhibitor,H-BIOA-002-3
234,BRD-A49734948-001-03-3,Plant alkaloid,H-BIOA-002-3
235,BRD-A49906757-004-03-1,Acetylcholine receptor antagonist,H-BIOA-002-3
236,BRD-A50157456-065-02-4,adrenergic receptor agonist,H-BIOA-002-3
237,BRD-A50311610-300-04-7,CAR agonist,H-BIOA-002-3
238,BRD-A50675702-001-03-0,chloride channel blocker|GABA gated chloride channel blocker,H-BIOA-002-3
239,BRD-A50684349-001-01-5,dopamine receptor agonist,H-BIOA-002-3
240,BRD-A50737080-001-01-4,ATR kinase inhibitor,H-BIOA-002-3
241,BRD-A50764878-001-01-4,serotonin receptor antagonist,H-BIOA-002-3
242,BRD-A51410489-001-01-4,adrenergic receptor antagonist,H-BIOA-002-3
243,BRD-A51714012-001-02-3,Adrenergic inhibitor,H-BIOA-002-3
244,BRD-A51820102-008-04-0,Bacterial cell wall synthesis inhibitor,H-BIOA-002-3
245,BRD-A51829654-001-01-4,Serotonin receptor antagonist,H-BIOA-002-3
246,BRD-A52588987-004-04-1,Dopamine receptor antagonist,H-BIOA-002-3
247,BRD-A52660433-066-01-3,Monoamine oxidase inhibitor,H-BIOA-002-3
248,BRD-A52922642-001-02-9,L-type calcium channel blocker,H-BIOA-002-3
249,BRD-A53077924-236-01-4,Selective serotonin reuptake enhancer (SSRE),H-BIOA-002-3
250,BRD-A53416814-001-01-5,nitric oxide production inhibitor|phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator,H-BIOA-002-3
251,BRD-A53576514-003-03-1,Acetylcholine receptor antagonist,H-BIOA-002-3
252,BRD-A53952395-003-04-6,local anesthetic,H-BIOA-002-3
253,BRD-A54029483-001-01-5,endothelin receptor antagonist,H-BIOA-002-3
254,BRD-A54236247-003-02-7,Adrenergic receptor agonist,H-BIOA-002-3
255,BRD-A54490543-066-04-4,monoamine oxidase inhibitor,H-BIOA-002-3
256,BRD-A54845972-066-01-5,serotonin receptor agonist|adrenergic receptor partial agonist|dopamine receptor agonist,H-BIOA-002-3
257,BRD-A54927599-001-07-8,P-selectin inhibitor,H-BIOA-002-3
258,BRD-A55272860-001-03-9,dopamine receptor antagonist,H-BIOA-002-3
259,BRD-A55369275-001-01-6,GABA receptor antagonist,H-BIOA-002-3
260,BRD-A55393291-001-02-4,Androgen receptor agonist,H-BIOA-002-3
261,BRD-A55424491-001-04-1,dihydrofolate reductase inhibitor,H-BIOA-002-3
262,BRD-A55756846-001-05-5,PKA inhibitor,H-BIOA-002-3
263,BRD-A55913614-316-04-7,antimalarial agent|DNA inhibitor,H-BIOA-002-3
264,BRD-A56020723-001-02-0,cathepsin inhibitor|antiamyloidogenic agent,H-BIOA-002-3
265,BRD-A56675431-001-04-0,Thiazide diuretic,H-BIOA-002-3
266,BRD-A56987319-001-03-8,Adenylyl cyclase inhibitor,H-BIOA-002-3
267,BRD-A57133233-003-03-7,histamine receptor antagonist,H-BIOA-002-3
268,BRD-A57382968-001-06-8,Cyclooxygenase inhibitor,H-BIOA-002-3
269,BRD-A58048407-001-06-3,Calcium channel blocker,H-BIOA-002-3
270,BRD-A59215453-003-03-3,Acetylcholine receptor antagonist,H-BIOA-002-3
271,BRD-A59303141-001-03-9,Thiazide diuretic,H-BIOA-002-3
272,BRD-A60197193-001-05-4,Dopamine receptor antagonist,H-BIOA-002-3
273,BRD-A61154809-001-03-5,ATP channel blocker|insulin secretagogue,H-BIOA-002-3
274,BRD-A61392169-001-01-9,glutamate receptor antagonist,H-BIOA-002-3
275,BRD-A61470182-001-02-4,macrophage activator,H-BIOA-002-3
276,BRD-A61793559-001-04-0,Carbonic anhydrase inhibitor,H-BIOA-002-3
277,BRD-A61856038-001-01-2,Lipoxygenase inhibitor,H-BIOA-002-3
278,BRD-A62021152-003-01-8,serotonin receptor agonist,H-BIOA-002-3
279,BRD-A62057054-001-01-5,Serotonin receptor antagonist,H-BIOA-002-3
280,BRD-A62428732-096-02-6,antihistamine,H-BIOA-002-3
281,BRD-A62505706-001-02-3,DNA directed DNA polymerase inhibitor,H-BIOA-002-3
282,BRD-A62525898-001-02-9,Glucocorticoid receptor agonist,H-BIOA-002-3
283,BRD-A63346720-300-01-1,sigma receptor antagonist|dopamine reuptake inhibitor,H-BIOA-002-3
284,BRD-A63546914-003-01-2,Glutamate receptor antagonist,H-BIOA-002-3
285,BRD-A63667919-103-01-9,dopamine receptor antagonist|partial serotonin receptor agonist,H-BIOA-002-3
286,BRD-A63836183-362-01-1,angiotensin receptor antagonist,H-BIOA-002-3
287,BRD-A63894585-001-03-4,glucocorticoid receptor agonist,H-BIOA-002-3
288,BRD-A64092382-003-03-5,Sodium channel blocker,H-BIOA-002-3
289,BRD-A64125466-236-02-0,choleretic agent,H-BIOA-002-3
290,BRD-A64227845-004-02-8,Dopamine receptor agonist,H-BIOA-002-3
291,BRD-A64228451-001-03-5,BTK inhibitor,H-BIOA-002-3
292,BRD-A64485570-001-02-9,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,H-BIOA-002-3
293,BRD-A64933752-001-01-0,adenosine receptor agonist,H-BIOA-002-3
294,BRD-A64977602-001-01-9,Adrenergic receptor antagonist,H-BIOA-002-3
295,BRD-A65013509-003-03-8,Acetylcholine receptor antagonist,H-BIOA-002-3
296,BRD-A65051990-001-03-8,vitamin K antagonist,H-BIOA-002-3
297,BRD-A65076780-001-01-3,adrenergic receptor antagonist|prolactin inhibitor,H-BIOA-002-3
298,BRD-A65145453-001-02-0,glutamate receptor agonist,H-BIOA-002-3
299,BRD-A65280694-003-03-8,Dopamine receptor antagonist,H-BIOA-002-3
300,BRD-A65440446-001-02-5,Adrenergic receptor agonist,H-BIOA-002-3
301,BRD-A65597028-003-02-4,Adrenergic receptor antagonist,H-BIOA-002-3
302,BRD-A65615053-003-01-4,Serotonin receptor antagonist,H-BIOA-002-3
303,BRD-A65671304-001-02-6,angiotensin receptor antagonist,H-BIOA-002-3
304,BRD-A66025870-237-05-1,bacterial cell wall synthesis inhibitor,H-BIOA-002-3
305,BRD-A66199457-001-02-2,antineoplastic,H-BIOA-002-3
306,BRD-A66435872-313-01-8,Histamine receptor agonist,H-BIOA-002-3
307,BRD-A66563878-003-01-8,Adrenergic receptor agonist,H-BIOA-002-3
308,BRD-A66927094-001-01-7,Dopamine receptor antagonist,H-BIOA-002-3
309,BRD-A67552019-001-02-2,ATPase inhibitor,H-BIOA-002-3
310,BRD-A67862938-034-04-0,Adrenergic receptor antagonist,H-BIOA-002-3
311,BRD-A68039575-001-02-5,Aromatase inhibitor,H-BIOA-006-3
312,BRD-A68281735-001-02-0,Leukotriene receptor antagonist,H-BIOA-002-3
313,BRD-A68723818-050-04-4,Histamine receptor antagonist,H-BIOA-002-3
314,BRD-A68888262-003-02-9,histamine receptor antagonist,H-BIOA-002-3
315,BRD-A68929948-001-01-9,antiamyloidogenic agent|gamma secretase inhibitor,H-BIOA-002-3
316,BRD-A69636825-003-02-1,Calcium channel blocker,H-BIOA-002-3
317,BRD-A69777949-001-04-4,topoisomerase inhibitor,H-BIOA-002-3
318,BRD-A69786436-003-02-5,acetylcholine receptor antagonist,H-BIOA-002-3
319,BRD-A70083328-001-02-9,Acetylcholinesterase inhibitor,H-BIOA-002-3
320,BRD-A70268693-103-01-9,Acetylcholine receptor agonist,H-BIOA-002-3
321,BRD-A70407468-001-01-2,adenosine receptor antagonist,H-BIOA-002-3
322,BRD-A70514680-003-03-9,Local anesthetic,H-BIOA-002-3
323,BRD-A70649075-008-04-3,sterol demethylase inhibitor,H-BIOA-002-3
324,BRD-A71157293-003-03-5,Vitamin B,H-BIOA-002-3
325,BRD-A71203467-001-01-5,Dopamine receptor antagonist,H-BIOA-002-3
326,BRD-A71774530-001-01-8,chitin inhibitor,H-BIOA-002-3
327,BRD-A71816415-236-02-7,HMGCR inhibitor,H-BIOA-002-3
328,BRD-A72066420-001-01-1,PPAR receptor antagonist,H-BIOA-002-3
329,BRD-A72483914-001-01-1,Serotonin receptor antagonist,H-BIOA-002-3
330,BRD-A72596465-001-01-3,PPAR receptor antagonist,H-BIOA-002-3
331,BRD-A72703248-001-02-7,calcium channel blocker|cytochrome P450 inhibitor,H-BIOA-002-3
332,BRD-A72711497-236-02-0,bacterial permeability inducer,H-BIOA-002-3
333,BRD-A72988804-001-03-8,Cyclooxygenase inhibitor,H-BIOA-002-3
334,BRD-A73368467-003-02-8,Histamine receptor antagonist,H-BIOA-002-3
335,BRD-A73859745-236-01-8,Apoptosis stimulant,H-BIOA-002-3
336,BRD-A74667430-001-04-6,Cyclooxygenase inhibitor,H-BIOA-002-3
337,BRD-A74904029-001-04-0,Casein kinase inhibitor,H-BIOA-002-3
338,BRD-A74980173-001-02-8,Bacterial DNA gyrase inhibitor,H-BIOA-002-3
339,BRD-A75455249-001-02-0,calcium channel modulator|mTOR inhibitor|sodium channel blocker,H-BIOA-006-3
340,BRD-A75478957-001-01-6,collagenase inhibitor|metalloproteinase inhibitor|stromelysin inhibitor,H-BIOA-002-3
341,BRD-A75552914-001-04-4,Cyclooxygenase inhibitor,H-BIOA-002-3
342,BRD-A75769826-003-01-3,opioid receptor antagonist,H-BIOA-002-3
343,BRD-A75817871-001-02-6,ATPase inhibitor,H-BIOA-002-3
344,BRD-A75850590-003-04-9,bacterial DNA gyrase inhibitor,H-BIOA-002-3
345,BRD-A76093993-001-01-8,Potassium channel activator,H-BIOA-002-3
346,BRD-A77291778-003-04-8,acetylcholine receptor antagonist,H-BIOA-002-3
347,BRD-A77299732-001-01-6,Eukaryotic translation initiation factor inhibitor,H-BIOA-002-3
348,BRD-A77349281-001-02-2,heparanase inhibitor|tyrosine phosphatase inhibitor,H-BIOA-002-3
349,BRD-A78295502-337-03-5,anti-arrhythmia agent,H-BIOA-002-3
350,BRD-A78377521-001-02-2,Kinesin-like spindle protein inhibitor,H-BIOA-002-3
351,BRD-A78877355-003-03-6,Cyclooxygenase inhibitor,H-BIOA-002-3
352,BRD-A78942461-003-01-3,Adrenergic receptor antagonist,H-BIOA-002-3
353,BRD-A79226577-003-01-1,serotonin receptor antagonist|polarization inhibitor|sodium channel blocker,H-BIOA-002-3
354,BRD-A79672927-001-04-1,Acetylcholine receptor antagonist,H-BIOA-002-3
355,BRD-A79981887-003-04-0,adrenergic receptor agonist,H-BIOA-002-3
356,BRD-A80017228-001-04-2,Sodium/potassium/chloride transporter inhibitor,H-BIOA-002-3
357,BRD-A80213327-305-01-8,Ras GTPase inhibitor,H-BIOA-002-3
358,BRD-A80594172-001-02-0,glucocorticoid receptor agonist,H-BIOA-002-3
359,BRD-A80641450-001-01-4,Endothelin receptor antagonist,H-BIOA-002-3
360,BRD-A81177136-001-03-6,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,H-BIOA-002-3
361,BRD-A81615860-001-02-9,tryptophan hydroxylase inhibitor,H-BIOA-002-3
362,BRD-A81795050-003-01-7,oxidosqualene cyclase inhibitor,H-BIOA-002-3
363,BRD-A81866333-003-01-5,Adenosine receptor agonist,H-BIOA-002-3
364,BRD-A82238138-001-01-7,glucocorticoid receptor agonist,H-BIOA-002-3
365,BRD-A82371568-001-01-5,ribonucleoside reductase inhibitor|DNA polymerase inhibitor|DNA repair enzyme inhibitor|DNA synthesis inhibitor|ribonucleotide reductase inhibitor,H-BIOA-002-3
366,BRD-A82590476-001-01-1,tachykinin antagonist,H-BIOA-002-3
367,BRD-A82656074-003-01-2,opioid receptor antagonist,H-BIOA-002-3
368,BRD-A83326220-001-02-6,Nitric oxide production inhibitor,H-BIOA-002-3
369,BRD-A83431637-001-01-3,Cytochrome P450 inhibitor,H-BIOA-002-3
370,BRD-A83695761-001-01-1,Potassium channel blocker,H-BIOA-002-3
371,BRD-A83855350-003-01-4,Opioid receptor antagonist,H-BIOA-002-3
372,BRD-A83937277-001-03-0,Hydantoin antiepileptic,H-BIOA-002-3
373,BRD-A84174393-001-02-0,Cyclooxygenase inhibitor,H-BIOA-002-3
374,BRD-A84174873-001-06-0,benzodiazepine receptor agonist,H-BIOA-002-3
375,BRD-A84389091-001-01-1,GABA receptor inverse agonist,H-BIOA-002-3
376,BRD-A84389633-001-01-6,serotonin receptor antagonist,H-BIOA-002-3
377,BRD-A85137183-001-01-2,bacterial cell wall synthesis inhibitor,H-BIOA-002-3
378,BRD-A85234536-001-04-5,Adenosine receptor agonist,H-BIOA-002-3
379,BRD-A85280935-003-01-7,Dopamine receptor agonist,H-BIOA-002-3
380,BRD-A85472596-001-01-4,Prostanoid receptor antagonist,H-BIOA-002-3
381,BRD-A85587465-001-01-7,Serotonin receptor antagonist,H-BIOA-002-3
382,BRD-A86044036-001-04-2,cyclooxygenase inhibitor,H-BIOA-002-3
383,BRD-A87479750-001-01-9,Cyclooxygenase inhibitor,H-BIOA-002-3
384,BRD-A87719232-001-02-4,Cyclooxygenase inhibitor,H-BIOA-002-3
385,BRD-A88254928-001-04-6,adrenergic receptor agonist,H-BIOA-002-3
386,BRD-A88282067-001-02-2,Antiarrhythmic,H-BIOA-002-3
387,BRD-A88548664-001-01-5,dopamine receptor agonist,H-BIOA-002-3
388,BRD-A89434049-001-02-1,ATPase inhibitor,H-BIOA-002-3
389,BRD-A89585551-003-03-4,adenosine receptor antagonist|hemoglobin antagonist,H-BIOA-002-3
390,BRD-A89672324-001-02-2,GABA receptor antagonist,H-BIOA-002-3
391,BRD-A89947015-001-01-4,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,H-BIOA-002-3
392,BRD-A90311807-236-01-4,Dehydropeptidase inhibitor,H-BIOA-002-3
393,BRD-A90462498-003-02-1,antineoplastic,H-BIOA-002-3
394,BRD-A90490067-001-01-9,estrogen receptor antagonist|DNA directed DNA polymerase inhibitor|soluble epoxide hydrolase inhibitor,H-BIOA-002-3
395,BRD-A90515964-001-05-8,expectorant,H-BIOA-002-3
396,BRD-A90799790-001-04-1,calcium channel blocker,H-BIOA-002-3
397,BRD-A91008255-001-02-8,calcium channel blocker,H-BIOA-002-3
398,BRD-A91699651-316-04-2,Antimalarial,H-BIOA-002-3
399,BRD-A91866971-001-02-2,Thromboxane receptor antagonist,H-BIOA-002-3
400,BRD-A92161634-001-02-6,Acetylcholine receptor antagonist,H-BIOA-002-3
401,BRD-A92585442-237-01-0,Cytochrome P450 inhibitor,H-BIOA-002-3
402,BRD-A92670106-003-03-9,Sodium channel blocker,H-BIOA-002-3
403,BRD-A92826379-009-02-6,Sodium channel blocker,H-BIOA-002-3
404,BRD-A93000692-001-03-2,PPAR receptor agonist,H-BIOA-002-3
405,BRD-A93206962-001-01-2,adrenergic receptor agonist|adrenergic receptor partial agonist,H-BIOA-002-3
406,BRD-A93255169-001-06-9,TNF production inhibitor,H-BIOA-002-3
407,BRD-A93477898-001-01-8,caspase activator,H-BIOA-002-3
408,BRD-A93659613-051-03-6,Opioid receptor agonist,H-BIOA-002-3
409,BRD-A93739713-065-02-7,muscarinic antagonist,H-BIOA-002-3
410,BRD-A94413429-003-01-6,neuropeptide receptor antagonist,H-BIOA-002-3
411,BRD-A94543220-001-02-3,Sterol demethylase inhibitor,H-BIOA-002-3
412,BRD-A94624445-236-02-2,adenosine receptor agonist|cAMP stimulant,H-BIOA-002-3
413,BRD-A94669766-001-02-6,Aromatase inhibitor,H-BIOA-002-3
414,BRD-A94709349-001-02-6,Muscle relaxant,H-BIOA-002-3
415,BRD-A95096829-300-01-4,dopamine receptor antagonist,H-BIOA-002-3
416,BRD-A95207036-001-02-8,androgen receptor antagonist,H-BIOA-002-3
417,BRD-A95445494-001-02-9,interleukin synthesis inhibitor|sodium/glucose cotransporter inhibitor,H-BIOA-002-3
418,BRD-A95513702-001-02-2,aromatase inhibitor,H-BIOA-002-3
419,BRD-A95696066-003-06-2,Norepinephrine reuptake inhibitor,H-BIOA-002-3
420,BRD-A95869247-001-03-8,thiazide diuretic,H-BIOA-002-3
421,BRD-A95939040-008-03-3,sterol demethylase inhibitor,H-BIOA-002-3
422,BRD-A96456596-001-01-4,Leukotriene receptor antagonist,H-BIOA-002-3
423,BRD-A96485169-001-02-8,Aldose reductase inhibitor,H-BIOA-002-3
424,BRD-A96882008-001-01-3,Tachykinin antagonist,H-BIOA-002-3
425,BRD-A96897502-001-02-0,lipid peroxidase inhibitor,H-BIOA-002-3
426,BRD-A97104540-004-04-4,adrenergic receptor agonist,H-BIOA-003-3
427,BRD-A97479839-003-04-2,Acetylcholine receptor antagonist,H-BIOA-003-3
428,BRD-A97701745-001-04-6,adrenergic receptor antagonist|serotonin receptor antagonist,H-BIOA-003-3
429,BRD-A97730597-003-03-2,sodium channel blocker,H-BIOA-003-3
430,BRD-A97739905-001-04-2,cyclooxygenase inhibitor,H-BIOA-003-3
431,BRD-A98299281-050-03-9,calcium channel activator,H-BIOA-003-3
432,BRD-A98378129-001-01-4,cyclooxygenase inhibitor|calcium channel blocker|calcium-activated chloride channel blocker|mucin production inhibitor,H-BIOA-003-3
433,BRD-A98702003-304-02-2,11-beta-HSD1 inhibitor,H-BIOA-003-3
434,BRD-A98725278-103-01-9,serotonin receptor antagonist,H-BIOA-003-3
435,BRD-A99177642-001-02-5,acetylcholine receptor antagonist,H-BIOA-003-3
436,BRD-A99402294-236-02-0,bacterial cell wall synthesis inhibitor,H-BIOA-003-3
437,BRD-A99411506-002-01-3,antioxidant,H-BIOA-003-3
438,BRD-A99449986-001-01-4,adenine nucleotide translocase inhibitor|caspase activator|neurotrophic agent,H-BIOA-003-3
439,BRD-A99571536-001-01-0,anti-epileptic,H-BIOA-003-3
440,BRD-K00141480-001-03-0,anti-inflammatory agent|interleukin inhibitor,H-BIOA-003-3
441,BRD-K00184207-001-02-4,aryl hydrocarbon receptor ligand,H-BIOA-003-3
442,BRD-K00206590-001-01-2,ATP channel activator,H-BIOA-003-3
443,BRD-K00259736-001-03-2,microtubule inhibitor,H-BIOA-003-3
444,BRD-K00312224-001-03-8,estrogen receptor agonist,H-BIOA-003-3
445,BRD-K00603606-003-03-4,purinergic receptor antagonist|platelet aggregation inhibitor,H-BIOA-003-3
446,BRD-K00610438-003-01-7,serotonin receptor antagonist|collagen stimulant,H-BIOA-003-3
447,BRD-K00662280-001-01-1,GABA receptor agonist,H-BIOA-003-3
448,BRD-K00673382-001-04-9,histamine receptor antagonist,H-BIOA-003-3
449,BRD-K00675675-003-01-2,metalloproteinase inhibitor,H-BIOA-003-3
450,BRD-K00824317-001-03-0,glucocorticoid receptor agonist,H-BIOA-003-3
451,BRD-K01095011-001-03-5,5 alpha reductase inhibitor,H-BIOA-003-3
452,BRD-K01244426-236-04-8,bacterial cell wall synthesis inhibitor,H-BIOA-003-3
453,BRD-K01292756-001-06-0,dopamine receptor antagonist,H-BIOA-003-3
454,BRD-K01555864-001-02-8,antineoplastic,H-BIOA-006-3
455,BRD-K01567962-001-06-5,JNK inhibitor,H-BIOA-003-3
456,BRD-K01624546-001-02-8,LTB4 inhibitor,H-BIOA-003-3
457,BRD-K01648091-001-04-2,Dopamine receptor antagonist,H-BIOA-003-3
458,BRD-K01663662-003-03-8,muscarinic antagonist,H-BIOA-003-3
459,BRD-K01815685-001-02-3,aryl hydrocarbon receptor agonist,H-BIOA-003-3
460,BRD-K01868942-001-01-3,serotonin receptor antagonist,H-BIOA-003-3
461,BRD-K01902415-001-03-4,PPAR receptor agonist,H-BIOA-003-3
462,BRD-K02265150-001-04-2,norepinephrine reputake inhibitor,H-BIOA-003-3
463,BRD-K02275692-003-03-4,bacterial cell wall synthesis inhibitor,H-BIOA-003-3
464,BRD-K02283807-003-01-4,thromboxane receptor antagonist,H-BIOA-003-3
465,BRD-K02404261-001-02-7,Adenosine receptor antagonist,H-BIOA-003-3
466,BRD-K02407574-001-03-0,tubulin polymerization inhibitor,H-BIOA-003-3
467,BRD-K02581333-001-01-8,Tyrosine phosphatase inhibitor,H-BIOA-003-3
468,BRD-K02590140-001-01-2,cannabinoid receptor antagonist,H-BIOA-003-3
469,BRD-K02607075-333-03-6,Acetylcholine receptor antagonist,H-BIOA-003-3
470,BRD-K02637541-001-02-4,Cyclooxygenase inhibitor,H-BIOA-003-3
471,BRD-K02764365-001-03-7,anthelmintic agent,H-BIOA-003-3
472,BRD-K02867583-300-04-8,serotonin reuptake inhibitor,H-BIOA-003-3
473,BRD-K02900412-001-02-2,protein synthesis inhibitor,H-BIOA-003-3
474,BRD-K02953697-001-01-9,cytochrome P450 inhibitor,H-BIOA-003-3
475,BRD-K03015355-003-01-5,adenylyl cyclase activator|Adenylate cyclase stimulant|growth hormone receptor agonist|phosphokinase stimulant,H-BIOA-003-3
476,BRD-K03067624-300-02-9,protein synthesis inhibitor,H-BIOA-003-3
477,BRD-K03109492-001-01-4,CDC inhibitor,H-BIOA-003-3
478,BRD-K03384561-001-01-9,Angiogenesis inhibitor,H-BIOA-003-3
479,BRD-K03440695-001-02-6,Acetylcholine receptor antagonist,H-BIOA-003-3
480,BRD-K03600606-001-02-3,Beta secretase inhibitor,H-BIOA-003-3
481,BRD-K03602135-236-02-1,HMGCR inhibitor,H-BIOA-003-3
482,BRD-K03642198-300-01-7,hedgehog pathway inhibitor,H-BIOA-003-3
483,BRD-K03670461-001-02-0,EGFR inhibitor,H-BIOA-003-3
484,BRD-K03842655-001-02-1,potassium channel blocker,H-BIOA-003-3
485,BRD-K03981224-001-02-9,Progestogen hormone,H-BIOA-003-3
486,BRD-K04010869-001-02-6,HSP inducer|NFKB pathway inhibitor,H-BIOA-003-3
487,BRD-K04046242-001-03-6,Estrogen receptor agonist,H-BIOA-003-3
488,BRD-K04111260-001-01-9,Dopamine receptor antagonist,H-BIOA-003-3
489,BRD-K04170657-001-02-4,Ras GTPase inhibitor,H-BIOA-003-3
490,BRD-K04185004-003-03-6,Local anesthetic,H-BIOA-003-3
491,BRD-K04414442-001-03-4,tachykinin antagonist,H-BIOA-003-3
492,BRD-K04430056-001-02-9,nitric oxide synthase inhibitor,H-BIOA-003-3
493,BRD-K04704168-003-03-6,HCV inhibitor,H-BIOA-003-3
494,BRD-K04976539-001-01-0,PKC inhibitor|src inhibitor,H-BIOA-003-3
495,BRD-K05151076-001-01-8,estrogen receptor antagonist,H-BIOA-003-3
496,BRD-K05181084-003-02-9,dopamine receptor antagonist,H-BIOA-003-3
497,BRD-K05181463-001-01-6,Dopamine receptor antagonist,H-BIOA-003-3
498,BRD-K05434375-001-04-0,calcium channel blocker,H-BIOA-003-3
499,BRD-K05464208-001-01-6,p38 MAPK inhibitor,H-BIOA-003-3
500,BRD-K05653692-001-02-5,Glucosyltransferase inhibitor,H-BIOA-003-3
501,BRD-K05673000-323-02-8,Bacterial cell wall synthesis inhibitor,H-BIOA-003-3
502,BRD-K05901394-001-01-1,Dopamine receptor agonist,H-BIOA-003-3
503,BRD-K05906022-001-02-8,HIV protease inhibitor,H-BIOA-003-3
504,BRD-K05977355-001-02-6,sterol demethylase inhibitor,H-BIOA-003-3
505,BRD-K06014311-001-01-2,Melatonin receptor antagonist,H-BIOA-003-3
506,BRD-K06024458-001-01-4,cannabinoid receptor agonist,H-BIOA-003-3
507,BRD-K06147391-003-01-9,Acetylcholine receptor antagonist,H-BIOA-003-3
508,BRD-K06159959-001-01-2,Inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites,H-BIOA-003-3
509,BRD-K06208435-001-02-9,Calcium channel blocker,H-BIOA-003-3
510,BRD-K06221026-001-03-5,Cyclooxygenase inhibitor,H-BIOA-003-3
511,BRD-K06234293-001-01-8,TGF beta receptor inhibitor|p38 MAPK inhibitor,H-BIOA-003-3
512,BRD-K06426971-001-01-9,histone lyinse methyltransferase inhibitor,H-BIOA-003-3
513,BRD-K06467078-001-01-5,Adrenergic receptor antagonist,H-BIOA-003-3
514,BRD-K06543683-001-03-6,PKC inhibitor|glycogen synthase kinase inhibitor|leucine rich repeat kinase inhibitor|SIRT inhibitor,H-BIOA-003-3
515,BRD-K06593056-001-01-4,retinoid receptor agonist,H-BIOA-003-3
516,BRD-K06753942-001-02-0,MEK inhibitor,H-BIOA-003-3
517,BRD-K06854232-001-03-3,retinoid receptor agonist,H-BIOA-003-3
518,BRD-K06980535-003-04-4,Dopamine receptor antagonist,H-BIOA-003-3
519,BRD-K07117950-001-02-6,CDK inhibitor,H-BIOA-003-3
520,BRD-K07212038-001-02-1,Mast cell stabilizer,H-BIOA-003-3
521,BRD-K07220430-001-03-6,Calcium channel blocker,H-BIOA-003-3
522,BRD-K07325606-001-02-3,PKC inhibitor,H-BIOA-003-3
523,BRD-K07507905-236-01-8,adrenergic receptor agonist,H-BIOA-003-3
524,BRD-K07691486-001-05-6,CDK inhibitor,H-BIOA-003-3
525,BRD-K07762753-001-03-6,CDK inhibitor|tyrosine kinase inhibitor,H-BIOA-006-3
526,BRD-K07888196-001-01-8,IGF-1 inhibitor,H-BIOA-003-3
527,BRD-K08078237-001-04-0,calcium channel blocker,H-BIOA-003-3
528,BRD-K08109516-001-01-1,glutamate receptor antagonist,H-BIOA-003-3
529,BRD-K08115555-001-02-8,catechol O methyltransferase inhibitor|tumor necrosis factor inhibitor,H-BIOA-003-3
530,BRD-K08132273-001-01-6,EGFR inhibitor,H-BIOA-003-3
531,BRD-K08219523-001-01-9,Serotonin receptor agonist,H-BIOA-003-3
532,BRD-K08252256-236-04-9,Cyclooxygenase inhibitor,H-BIOA-003-3
533,BRD-K08287586-001-03-6,DNA synthesis inhibitor,H-BIOA-003-3
534,BRD-K08316444-001-02-7,inhibitor of mitochondrial electron transport,H-BIOA-003-3
535,BRD-K08438429-001-01-0,glucosylceramidase inhibitor|somatostatin receptor agonist,H-BIOA-003-3
536,BRD-K08554278-001-02-4,DNA binding agent,H-BIOA-003-3
537,BRD-K08619574-334-03-9,Dopamine receptor antagonist,H-BIOA-003-3
538,BRD-K08619838-300-03-2,Acetylcholine receptor agonist,H-BIOA-003-3
539,BRD-K08640512-003-01-5,Adrenergic receptor antagonist,H-BIOA-003-3
540,BRD-K08806317-050-03-6,Adrenergic receptor antagonist,H-BIOA-003-3
541,BRD-K08890269-001-01-5,Sodium channel blocker,H-BIOA-003-3
542,BRD-K08973992-001-01-3,Oxidative stress inducer,H-BIOA-003-3
543,BRD-K08996725-313-01-7,histamine receptor antagonist,H-BIOA-003-3
544,BRD-K08998509-001-01-6,dopamine receptor antagonist|serotonin receptor antagonist,H-BIOA-003-3
545,BRD-K09132007-001-01-8,casein kinase inhibitor|TGF beta receptor inhibitor,H-BIOA-003-3
546,BRD-K09255212-001-03-4,chelating agent,H-BIOA-003-3
547,BRD-K09397065-001-01-6,Serotonin receptor agonist,H-BIOA-003-3
548,BRD-K09416995-001-16-7,HMGCR inhibitor,H-BIOA-003-3
549,BRD-K09471561-001-02-6,bacterial DNA gyrase inhibitor,H-BIOA-003-3
550,BRD-K09497549-001-03-6,calcium channel modulator|mTOR inhibitor|sodium channel blocker,H-BIOA-006-3
551,BRD-K09537769-001-01-6,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,H-BIOA-003-3
552,BRD-K09549677-300-01-8,T-type calcium channel blocker|angiogenesis inhibitor|calcium channel blocker|calcium channel inhibitor|L-type calcium channel blocker|sodium channel blocker,H-BIOA-003-3
553,BRD-K09598619-065-01-5,tubulin polymerization inhibitor,H-BIOA-003-3
554,BRD-K09631521-001-02-4,cytochrome P450 inhibitor,H-BIOA-003-3
555,BRD-K09635134-001-02-4,negative control for D-erythro-MAPP,H-BIOA-003-3
556,BRD-K09635314-001-01-8,phospholipase activator,H-BIOA-003-3
557,BRD-K09668667-001-02-0,Carcinogen,H-BIOA-003-3
558,BRD-K09764130-001-02-6,Cannabinoid receptor agonist,H-BIOA-003-3
559,BRD-K09778810-001-01-5,inositol monophosphatase inhibitor,H-BIOA-003-3
560,BRD-K09963420-066-03-4,HIV protease inhibitor,H-BIOA-003-3
561,BRD-K09991945-001-02-0,glycogen synthase kinase inhibitor|PKC inhibitor|superoxide dismutase expression inhibitor,H-BIOA-006-3
562,BRD-K10042277-001-02-7,cetylcholine receptor agonist|dopamine receptor agonist|dopamine receptor antagonist|dopamine receptor partial agonist|serotonin receptor antagonist|serotonin receptor inverse agonist,H-BIOA-003-3
563,BRD-K10065684-001-02-5,laxative,H-BIOA-003-3
564,BRD-K10176267-001-01-7,glutamate receptor antagonist,H-BIOA-003-3
565,BRD-K10177585-003-01-6,Adenosine receptor antagonist,H-BIOA-003-3
566,BRD-K10207760-236-03-0,bacterial permeability inducer,H-BIOA-003-3
567,BRD-K10314788-003-04-4,nootropic agent,H-BIOA-003-3
568,BRD-K10670311-001-04-9,Antirheumatic,H-BIOA-003-3
569,BRD-K10705233-001-01-4,Cannabinoid receptor agonist,H-BIOA-003-3
570,BRD-K10843433-001-02-9,Cyclooxygenase inhibitor,H-BIOA-003-3
571,BRD-K10870738-001-02-4,lipoxygenase inhibitor,H-BIOA-003-3
572,BRD-K10974103-001-03-9,Protein synthesis inhibitor,H-BIOA-003-3
573,BRD-K10995081-001-05-5,Dopamine receptor antagonist,H-BIOA-003-3
574,BRD-K11107424-001-01-1,histamine receptor antagonist,H-BIOA-003-3
575,BRD-K11129031-001-04-4,Lipoprotein lipase activator,H-BIOA-003-3
576,BRD-K11158509-001-02-0,EGFR inhibitor,H-BIOA-003-3
577,BRD-K11163873-001-02-8,PARP inhibitor,H-BIOA-003-3
578,BRD-K11298197-001-03-9,protein synthesis inhibitor,H-BIOA-003-3
579,BRD-K11373525-003-01-3,Angiotensin receptor antagonist,H-BIOA-003-3
580,BRD-K11399644-003-03-0,AMPK activator,H-BIOA-003-3
581,BRD-K11634954-300-01-8,dopamine uptake inhibitor,H-BIOA-003-3
582,BRD-K11696279-003-01-5,Imidazoline receptor agonist,H-BIOA-003-3
583,BRD-K11717138-001-03-0,chloride channel blocker,H-BIOA-003-3
584,BRD-K11742128-003-04-4,histamine receptor antagonist,H-BIOA-003-3
585,BRD-K11911061-003-02-8,serotonin receptor antagonist,H-BIOA-003-3
586,BRD-K11927976-050-01-1,mediator release inhibitor|syk inhibitor,H-BIOA-003-3
587,BRD-K12102668-001-04-0,Monoamine oxidase inhibitor,H-BIOA-003-3
588,BRD-K12120659-305-01-4,Integrin antagonist,H-BIOA-003-3
589,BRD-K12184470-300-01-8,calcium channel blocker|T-type calcium channel blocker,H-BIOA-003-3
590,BRD-K12219985-001-04-8,Sulfonylurea,H-BIOA-003-3
591,BRD-K12244279-001-01-7,MEK inhibitor,H-BIOA-003-3
592,BRD-K12357156-001-01-5,EGFR inhibitor|ErbB2 inhibitor|JAK2 inhibitor,H-BIOA-003-3
593,BRD-K12513978-001-04-3,cyclooxygenase inhibitor,H-BIOA-003-3
594,BRD-K12539581-001-06-2,tubulin polymerization inhibitor,H-BIOA-003-3
595,BRD-K12932420-001-01-5,Phosphodiesterase inhibitor,H-BIOA-003-3
596,BRD-K12994359-001-02-8,Cyclooxygenase inhibitor,H-BIOA-003-3
597,BRD-K13169950-001-04-5,HDAC inhibitor,H-BIOA-003-3
598,BRD-K13211965-001-01-4,dopamine receptor antagonist,H-BIOA-003-3
599,BRD-K13261168-001-01-4,Dopamine receptor agonist,H-BIOA-003-3
600,BRD-K13356952-001-11-1,carbonic anhydrase inhibitor,H-BIOA-006-3
601,BRD-K13533483-001-03-0,calcineurin inhibitor|cyclophilin inhibitor|immunosuppressant|insulin expression inhibitor|T cell inhibitor,H-BIOA-003-3
602,BRD-K13544237-001-01-0,dopamine receptor agonist|antiamyloidogenic agent,H-BIOA-003-3
603,BRD-K13571841-001-03-7,Aspartic protease inhibitor,H-BIOA-003-3
604,BRD-K13642330-001-02-6,cytochrome P450 inhibitor,H-BIOA-003-3
605,BRD-K13819402-003-02-9,Acetylcholinesterase inhibitor,H-BIOA-003-3
606,BRD-K13994703-001-02-0,adrenergic receptor antagonist,H-BIOA-003-3
607,BRD-K14200658-001-02-6,Vesicular monoamine transporter inhibitor,H-BIOA-003-3
608,BRD-K14221570-236-01-1,HIV entry inhibitor,H-BIOA-003-3
609,BRD-K14282469-001-01-5,serotonin receptor antagonist,H-BIOA-003-3
610,BRD-K14441456-001-01-2,EGFR inhibitor,H-BIOA-003-3
611,BRD-K14496212-001-01-1,dopamine receptor agonist,H-BIOA-003-3
612,BRD-K14536225-001-02-7,Glucosidase inhibitor,H-BIOA-006-3
613,BRD-K14618467-003-01-8,IKK inhibitor,H-BIOA-003-3
614,BRD-K14765469-003-02-3,acetylcholinesterase inhibitor,H-BIOA-003-3
615,BRD-K14767410-001-01-5,cyclooxygenase inhibitor,H-BIOA-003-3
616,BRD-K14807180-001-01-7,serotonin receptor antagonist,H-BIOA-003-3
617,BRD-K14821540-001-02-1,mitochondrial oxidative phosphorylation uncoupler,H-BIOA-003-3
618,BRD-K14888893-001-02-3,KATP activator,H-BIOA-003-3
619,BRD-K14965640-001-03-3,Cyclooxygenase inhibitor,H-BIOA-003-3
620,BRD-K14993104-001-03-4,Chemoreceptor agonist,H-BIOA-003-3
621,BRD-K15025317-001-04-5,NFkB pathway inhibitor,H-BIOA-003-3
622,BRD-K15086322-103-01-0,histamine receptor antagonist|histamine receptor silent antagonist,H-BIOA-006-3
623,BRD-K15164005-001-01-5,carboxylesterase inhibitor,H-BIOA-003-3
624,BRD-K15196155-001-01-5,Hydroxycarboxylic acid receptor agonist,H-BIOA-003-3
625,BRD-K15519488-001-01-6,dopamine receptor agonist,H-BIOA-003-3
626,BRD-K15567136-001-01-1,phosphodiesterase inhibitor,H-BIOA-003-3
627,BRD-K15588452-003-01-9,serotonin receptor antagonist,H-BIOA-003-3
628,BRD-K15601958-001-01-3,Lysophospholipid receptor agonist,H-BIOA-003-3
629,BRD-K15616905-001-01-5,mitochondrial oxidative phosphorylation uncoupler,H-BIOA-003-3
630,BRD-K15715913-001-01-5,dopamine receptor antagonist|serotonin receptor antagonist,H-BIOA-003-3
631,BRD-K15766189-001-02-3,bacterial cell wall synthesis inhibitor,H-BIOA-003-3
632,BRD-K15791587-003-01-7,tachykinin antagonist,H-BIOA-003-3
633,BRD-K15868788-001-01-4,Serotonin receptor antagonist,H-BIOA-003-3
634,BRD-K15916496-001-04-8,cytochrome P450 inhibitor|imidazoline receptor ligand,H-BIOA-003-3
635,BRD-K15933101-003-01-2,dopamine receptor agonist|dopamine receptor modulator,H-BIOA-003-3
636,BRD-K15935639-001-02-0,PGPH inhibitor|proteasome inhibitor,H-BIOA-003-3
637,BRD-K15957397-001-02-6,CDC inhibitor,H-BIOA-003-3
638,BRD-K16195444-001-01-7,Adrenergic receptor agonist,H-BIOA-003-3
639,BRD-K16444452-001-03-4,phosphodiesterase inhibitor|leukotriene receptor antagonist|toll-like receptor antagonist|macrophage migration inhibiting factor inhibitor|macrophage migration inhibiting factor modulator|mediator release inhibitor|nitric oxide synthase inhibitor,H-BIOA-003-3
640,BRD-K16485616-001-01-4,HDAC inhibitor|cell cycle inhibitor,H-BIOA-003-3
641,BRD-K16508793-001-01-8,benzodiazepine receptor agonist,H-BIOA-003-3
642,BRD-K16542329-001-05-1,phosphodiesterase inhibitor,H-BIOA-003-3
643,BRD-K16551401-003-01-8,serotonin receptor agonist,H-BIOA-003-3
644,BRD-K16604360-001-01-8,antiamyloidogenic agent|dopamine receptor agonist,H-BIOA-003-3
645,BRD-K16664969-001-01-7,FLT3 inhibitor|tyrosine kinase inhibitor,H-BIOA-003-3
646,BRD-K16977723-001-01-0,EGFR inhibitor,H-BIOA-003-3
647,BRD-K17016787-001-03-5,estrogen receptor agonist,H-BIOA-003-3
648,BRD-K17140735-300-01-6,Proteasome inhibitor,H-BIOA-003-3
649,BRD-K17294426-050-04-0,dopamine receptor antagonist,H-BIOA-003-3
650,BRD-K17368287-001-03-5,11-beta hydroxysteroid dehydrogenase inhibitor,H-BIOA-003-3
651,BRD-K17378184-300-03-4,Dopamine receptor agonist,H-BIOA-003-3
652,BRD-K17415526-001-02-7,protein tyrosine kinase inhibitor,H-BIOA-003-3
653,BRD-K17497770-001-01-0,EGFR inhibitor|src inhibitor,H-BIOA-003-3
654,BRD-K17565903-066-04-1,muscle relaxant,H-BIOA-003-3
655,BRD-K17674993-001-03-1,Corticosteroid agonist,H-BIOA-003-3
656,BRD-K17693482-001-03-9,potassium channel activator,H-BIOA-003-3
657,BRD-K17705806-003-01-0,opioid receptor antagonist,H-BIOA-003-3
658,BRD-K17743125-001-01-9,HDAC inhibitor|cell cycle inhibitor,H-BIOA-003-3
659,BRD-K17743697-066-01-0,sodium/calcium exchange inhibitor,H-BIOA-003-3
660,BRD-K17796732-001-02-0,cannabinoid receptor agonist,H-BIOA-003-3
661,BRD-K17894950-001-04-4,CDK inhibitor|glycogen synthase kinase inhibitor,H-BIOA-003-3
662,BRD-K17896185-001-01-2,opioid receptor agonist,H-BIOA-003-3
663,BRD-K18059238-001-02-1,cyclooxygenase inhibitor|prostanoid receptor stimulant|thromboxane synthase stimulant,H-BIOA-003-3
664,BRD-K18194590-065-02-3,adrenergic receptor agonist,H-BIOA-003-3
665,BRD-K18250272-003-03-7,local anesthetic,H-BIOA-004-3
666,BRD-K18316707-001-01-9,cannabinoid receptor antagonist,H-BIOA-004-3
667,BRD-K18550767-001-02-8,interleukin inhibitor,H-BIOA-004-3
668,BRD-K18574842-323-03-3,bacterial cell wall synthesis inhibitor,H-BIOA-004-3
669,BRD-K18619710-001-03-7,steroid,H-BIOA-004-3
670,BRD-K18742343-001-03-2,PKA inhibitor,H-BIOA-004-3
671,BRD-K18757346-001-02-9,thromboxane receptor agonist,H-BIOA-004-3
672,BRD-K18779551-003-03-7,acetylcholine release stimulant|adrenergic transmitter uptake inhibitor|reducing agent,H-BIOA-004-3
673,BRD-K18787491-001-05-2,MEK inhibitor,H-BIOA-004-3
674,BRD-K18799075-001-01-0,cannabinoid receptor partial agonist,H-BIOA-004-3
675,BRD-K18816859-001-01-4,Serotonin receptor agonist,H-BIOA-004-3
676,BRD-K18909381-001-01-4,serotonin receptor agonist,H-BIOA-004-3
677,BRD-K18910433-001-04-4,estrogen receptor agonist,H-BIOA-004-3
678,BRD-K19111024-001-04-3,PPAR receptor agonist,H-BIOA-004-3
679,BRD-K19295594-001-04-4,BCL inhibitor|MCL1 inhibitor,H-BIOA-004-3
680,BRD-K19309090-300-03-0,acetylcholine receptor agonist,H-BIOA-004-3
681,BRD-K19352500-332-03-7,dopamine receptor antagonist,H-BIOA-004-3
682,BRD-K19360254-001-01-3,Dopamine receptor agonist,H-BIOA-004-3
683,BRD-K19462402-003-03-0,adrenergic receptor antagonist|calcium channel blocker,H-BIOA-004-3
684,BRD-K19533706-001-01-9,Angiogenesis inhibitor,H-BIOA-004-3
685,BRD-K19554809-001-01-1,serotonin receptor agonist,H-BIOA-004-3
686,BRD-K19605405-001-01-9,adenosine receptor antagonist,H-BIOA-004-3
687,BRD-K20141153-003-03-8,norepinephrine transporter inhibitor|adrenergic transmitter uptake inhibitor,H-BIOA-004-3
688,BRD-K20152659-001-02-0,Cholesterol inhibitor,H-BIOA-004-3
689,BRD-K20620780-001-01-0,dopamine receptor antagonist,H-BIOA-004-3
690,BRD-K20655524-003-04-7,psychoactive drug,H-BIOA-004-3
691,BRD-K20714604-001-01-5,Serotonin receptor partial agonist,H-BIOA-004-3
692,BRD-K20742498-001-01-5,serotonin receptor antagonist,H-BIOA-004-3
693,BRD-K20755323-001-01-8,sphingosine kinase inhibitor,H-BIOA-004-3
694,BRD-K20995441-001-01-7,Opioid receptor agonist,H-BIOA-004-3
695,BRD-K21283037-001-02-5,glutamate inhibitor,H-BIOA-004-3
696,BRD-K21350491-001-02-1,acid sensing ion channel blocker|sodium channel blockers|TRPP3 channel inhibitor|TRPV modulator,H-BIOA-004-3
697,BRD-K21450440-001-04-7,carbonic anhydrase inhibitor,H-BIOA-004-3
698,BRD-K21520694-001-02-4,PABA antagonist,H-BIOA-004-3
699,BRD-K21548250-001-01-3,sodium channel blocker,H-BIOA-004-3
700,BRD-K21565985-001-04-3,adrenergic receptor agonist,H-BIOA-004-3
701,BRD-K21667562-001-01-4,FAAH transport inhibitor|anandamide transport inhibitor|nucelar factor of activated T-cells inhibitor|TRPV agonist,H-BIOA-004-3
702,BRD-K21680192-300-05-2,topoisomerase inhibitor,H-BIOA-004-3
703,BRD-K21733600-001-02-6,cyclooxygenase inhibitor,H-BIOA-004-3
704,BRD-K21853356-001-04-4,EGFR inhibitor,H-BIOA-004-3
705,BRD-K22031190-001-04-6,Prostanoid receptor antagonist,H-BIOA-004-3
706,BRD-K22134346-001-04-1,HMGCR inhibitor,H-BIOA-004-3
707,BRD-K22193694-001-04-5,Topical sunscreen agent,H-BIOA-004-3
708,BRD-K22385716-001-01-7,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,H-BIOA-004-3
709,BRD-K22861715-001-03-4,breast cancer resistance protein inhibitor,H-BIOA-004-3
710,BRD-K22969690-001-02-6,bacterial 50S ribosomal subunit inhibitor,H-BIOA-004-3
711,BRD-K23301018-001-02-6,antiprotozoal agent,H-BIOA-004-3
712,BRD-K23335153-300-01-7,glutamate receptor positive allosteric modulator,H-BIOA-004-3
713,BRD-K23383398-001-01-6,LXR agonist|ABC transporter expression enhancer|ROR inverse agonist,H-BIOA-004-3
714,BRD-K23478508-001-03-7,ATPase inhibitor,H-BIOA-004-3
715,BRD-K23541596-300-04-9,histamine receptor agonist,H-BIOA-004-3
716,BRD-K23566484-001-04-5,androgen receptor antagonist,H-BIOA-004-3
717,BRD-K23583188-001-05-6,EGFR inhibitor|tyrosine kinase inhibitor,H-BIOA-004-3
718,BRD-K23623876-001-01-6,ultrasound contrast agent,H-BIOA-006-3
719,BRD-K23704908-001-03-2,serine protease inhibitor,H-BIOA-004-3
720,BRD-K23913458-001-02-5,Vitamin K antagonist,H-BIOA-004-3
721,BRD-K23922020-075-01-1,acetylcholine receptor agonist,H-BIOA-004-3
722,BRD-K24084088-001-02-2,adenosine receptor antagonist,H-BIOA-004-3
723,BRD-K24132293-001-02-0,glutathione transferase inhibitor,H-BIOA-004-3
724,BRD-K24201553-003-02-4,Serotonin receptor antagonist,H-BIOA-004-3
725,BRD-K24240364-003-02-1,Glutamate receptor antagonist,H-BIOA-004-3
726,BRD-K24396733-001-01-1,dopamine receptor agonist,H-BIOA-004-3
727,BRD-K24526313-001-08-6,Potassium channel activator,H-BIOA-004-3
728,BRD-K25224017-001-04-5,serotonin receptor antagonist,H-BIOA-004-3
729,BRD-K25394294-001-04-0,Cyclooxygenase inhibitor,H-BIOA-004-3
730,BRD-K25433859-003-11-4,norepinephrine reputake inhibitor|tricyclic antidepressant,H-BIOA-004-3
731,BRD-K25741894-001-03-8,acetylcholinesterase inhibitor,H-BIOA-004-3
732,BRD-K25875056-001-01-2,Protein tyrosine kinase activator,H-BIOA-004-3
733,BRD-K25906698-303-01-9,histamine receptor agonist,H-BIOA-004-3
734,BRD-K26160755-003-01-8,Imidazoline receptor agonist,H-BIOA-004-3
735,BRD-K26373640-001-02-8,IKK inhibitor,H-BIOA-004-3
736,BRD-K26429091-051-01-9,acetylcholine receptor antagonist,H-BIOA-004-3
737,BRD-K26521938-001-04-9,prostanoid receptor agonist,H-BIOA-004-3
738,BRD-K26548821-001-01-8,Dopamine receptor agonist,H-BIOA-004-3
739,BRD-K26573499-300-01-3,Adrenergic receptor agonist,H-BIOA-004-3
740,BRD-K26979635-001-01-1,Glutamate receptor antagonist,H-BIOA-004-3
741,BRD-K26997899-001-01-4,microtubule inhibitor|tubulin inhibitor,H-BIOA-004-3
742,BRD-K27141178-001-01-0,Serotonin receptor antagonist,H-BIOA-004-3
743,BRD-K27305650-001-04-2,mTOR inhibitor|PI3K inhibitor|DNA dependent protein kinase inhibitor|phosphodiesterase inhibitor|PLK inhibitor,H-BIOA-004-3
744,BRD-K27316855-001-02-6,vitamin D receptor agonist,H-BIOA-004-3
745,BRD-K27351809-001-02-0,progesterone receptor agonist,H-BIOA-004-3
746,BRD-K27450477-001-03-9,Adenosine deaminase inhibitor,H-BIOA-004-3
747,BRD-K27499107-001-02-6,IP receptor activator,H-BIOA-004-3
748,BRD-K27710560-001-02-6,SIRT inhibitor,H-BIOA-004-3
749,BRD-K27737647-001-03-4,PKA inhibitor,H-BIOA-004-3
750,BRD-K27871032-001-02-6,Ergoline alkaloid,H-BIOA-004-3
751,BRD-K28115081-001-01-9,Platelet activating factor receptor antagonist,H-BIOA-004-3
752,BRD-K28137194-003-01-3,GABA receptor agonist,H-BIOA-004-3
753,BRD-K28143534-001-01-4,histamine receptor antagonist,H-BIOA-004-3
754,BRD-K28183345-003-05-6,Dihydrofolate reductase inhibitor,H-BIOA-004-3
755,BRD-K28307902-001-04-3,androgen receptor antagonist,H-BIOA-004-3
756,BRD-K28453807-003-05-4,Cholinergic receptor antagonist,H-BIOA-004-3
757,BRD-K28578425-001-01-3,phosphodiesterase inhibitor,H-BIOA-004-3
758,BRD-K28667196-001-02-9,Increases arterial blood pressure,H-BIOA-004-3
759,BRD-K28680267-001-01-8,CCK receptor antagonist,H-BIOA-004-3
760,BRD-K28761384-003-03-6,dopamine receptor antagonist,H-BIOA-004-3
761,BRD-K28761891-001-01-0,melatonin receptor agonist,H-BIOA-004-3
762,BRD-K28806945-001-01-9,dopamine receptor antagonist,H-BIOA-004-3
763,BRD-K28863208-001-01-2,Cholinergic receptor agonist,H-BIOA-004-3
764,BRD-K28907958-001-01-9,retinoid receptor agonist,H-BIOA-004-3
765,BRD-K28936863-051-04-1,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,H-BIOA-004-3
766,BRD-K29113274-001-03-6,Sterol demethylase inhibitor,H-BIOA-004-3
767,BRD-K29178788-001-02-0,Furoquinoline alkaloid,H-BIOA-004-3
768,BRD-K29359156-001-04-6,H+/K+-ATPase inhibitor,H-BIOA-004-3
769,BRD-K29555132-001-02-2,Cannabinoid receptor agonist,H-BIOA-004-3
770,BRD-K29582677-001-02-7,Calcium channel blocker,H-BIOA-004-3
771,BRD-K29668683-300-01-4,sigma receptor antagonist,H-BIOA-004-3
772,BRD-K29673530-001-03-9,tyrosine kinase inhibitor,H-BIOA-004-3
773,BRD-K29950728-048-02-6,estrogen receptor antagonist,H-BIOA-004-3
774,BRD-K30197592-001-01-5,Serotonin receptor agonist,H-BIOA-004-3
775,BRD-K30240666-051-05-0,histamine receptor antagonist,H-BIOA-004-3
776,BRD-K30421593-050-02-3,adrenergic receptor antagonist,H-BIOA-004-3
777,BRD-K30480208-001-04-5,Electrolyte reabsorption inhibitor,H-BIOA-004-3
778,BRD-K30685142-001-04-8,thyroid hormone stimulant,H-BIOA-004-3
779,BRD-K30867024-001-01-1,serotonin receptor antagonist,H-BIOA-004-3
780,BRD-K30990140-003-01-6,Cyclooxygenase inhibitor,H-BIOA-004-3
781,BRD-K31054881-300-01-3,Adrenergic receptor antagonist,H-BIOA-004-3
782,BRD-K31238592-001-01-6,CCK receptor antagonist|gastrin inhibitor,H-BIOA-004-3
783,BRD-K31342827-001-05-4,PKC inhibitor,H-BIOA-004-3
784,BRD-K31491153-001-01-2,serotonin receptor agonist,H-BIOA-004-3
785,BRD-K31542390-001-01-5,dehydrogenase inhibitor|inositol monophosphatase inhibitor,H-BIOA-004-3
786,BRD-K31611373-001-02-7,Prostanoid receptor agonist,H-BIOA-004-3
787,BRD-K31627533-001-03-8,glucocorticoid receptor agonist,H-BIOA-004-3
788,BRD-K31633810-003-01-0,Acetylcholine receptor antagonist,H-BIOA-004-3
789,BRD-K31699485-001-01-9,glutamate receptor modulator,H-BIOA-004-3
790,BRD-K31792052-004-01-9,interleukin receptor antagonist,H-BIOA-004-3
791,BRD-K31843556-001-01-7,PPAR receptor anatagonist|PPAR receptor antagonist,H-BIOA-004-3
792,BRD-K31912990-003-01-0,neuropeptide receptor antagonist,H-BIOA-004-3
793,BRD-K31987754-001-01-2,Cannabinoid receptor agonist,H-BIOA-004-3
794,BRD-K32164935-001-06-8,ATP channel blocker,H-BIOA-004-3
795,BRD-K32247306-001-04-7,GABA receptor antagonist,H-BIOA-004-3
796,BRD-K32292990-001-01-0,EGFR inhibitor,H-BIOA-004-3
797,BRD-K32412559-001-01-7,Adrenergic receptor antagonist,H-BIOA-004-3
798,BRD-K32501161-001-01-7,dopamine uptake inhibitor,H-BIOA-004-3
799,BRD-K32526544-001-01-2,Potassium channel activator,H-BIOA-004-3
800,BRD-K32584078-001-02-3,AKT inhibitor|HCV NS5B RdRp inhibitor,H-BIOA-004-3
801,BRD-K32645441-001-01-4,serotonin receptor agonist,H-BIOA-004-3
802,BRD-K32696739-001-02-6,Monoamine oxidase inhibitor,H-BIOA-004-3
803,BRD-K32744045-001-04-9,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,H-BIOA-004-3
804,BRD-K32755366-003-03-4,Norepinephrine transporter inhibitor,H-BIOA-004-3
805,BRD-K32821942-001-04-9,dehydrogenase inhibitor,H-BIOA-004-3
806,BRD-K32828673-001-01-5,tubulin polymerization inhibitor,H-BIOA-004-3
807,BRD-K32830106-003-11-3,adrenergic receptor agonist,H-BIOA-004-3
808,BRD-K33204703-001-04-6,PDGFR receptor inhibitor,H-BIOA-004-3
809,BRD-K33211335-337-03-7,glutamate receptor antagonist|sigma receptor agonist,H-BIOA-004-3
810,BRD-K33308633-001-01-6,calcineurin inhibitor,H-BIOA-004-3
811,BRD-K33396764-001-02-0,Omega 3 fatty acid stimulant,H-BIOA-004-3
812,BRD-K33453211-003-03-2,Histamine receptor antagonist,H-BIOA-004-3
813,BRD-K33459542-001-02-5,sigma receptor agonist,H-BIOA-004-3
814,BRD-K33583600-001-03-9,guanylate cyclase activator,H-BIOA-004-3
815,BRD-K33710385-001-05-4,mycolic synthesis inhibitor,H-BIOA-004-3
816,BRD-K33818169-003-01-2,LXR agonist|ABC transporter expression enhancer,H-BIOA-004-3
817,BRD-K33864865-001-01-7,CCK receptor antagonist,H-BIOA-004-3
818,BRD-K33882852-003-01-0,benzodiazepine receptor agonist,H-BIOA-004-3
819,BRD-K34014345-001-02-6,Anti-inflammatory,H-BIOA-004-3
820,BRD-K34034388-300-01-0,dopamine uptake inhibitor,H-BIOA-004-3
821,BRD-K34092021-001-02-3,TRPV agonist|cannabinoid receptor agonist,H-BIOA-004-3
822,BRD-K34154330-003-04-9,GABA receptor modulator,H-BIOA-004-3
823,BRD-K34170797-001-01-1,FXR agonist,H-BIOA-004-3
824,BRD-K34415467-003-04-9,histamine receptor antagonist,H-BIOA-004-3
825,BRD-K34568562-001-02-7,interferon inducer,H-BIOA-004-3
826,BRD-K34608650-001-01-6,Cannabinoid receptor agonist,H-BIOA-004-3
827,BRD-K34685430-001-01-1,dopamine receptor antagonist|serotonin receptor antagonist,H-BIOA-004-3
828,BRD-K34995470-001-02-3,receptor tyrosine protein kinase inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor,H-BIOA-004-3
829,BRD-K35240538-001-03-1,glucocorticoid receptor agonist,H-BIOA-004-3
830,BRD-K35430135-003-01-5,Adrenergic receptor antagonist,H-BIOA-004-3
831,BRD-K35458079-001-04-2,Nootropic agent,H-BIOA-004-3
832,BRD-K35498378-001-03-8,Aldose reductase inhibitor,H-BIOA-004-3
833,BRD-K35629949-001-01-2,CCK receptor antagonist,H-BIOA-004-3
834,BRD-K35708212-331-03-1,ATPase inhibitor,H-BIOA-004-3
835,BRD-K35941380-001-01-7,Serotonin receptor antagonist,H-BIOA-004-3
836,BRD-K35960502-001-04-4,DNA replication inhibitor|STAT inhibitor,H-BIOA-004-3
837,BRD-K36007650-300-02-3,protein synthesis inhibitor,H-BIOA-004-3
838,BRD-K36009368-001-01-8,Opioid receptor agonist,H-BIOA-004-3
839,BRD-K36021395-300-01-6,adenosine kinase inhibitor,H-BIOA-004-3
840,BRD-K36055864-001-04-4,protein synthesis inhibitor,H-BIOA-004-3
841,BRD-K36116267-001-05-4,psychoactive drug,H-BIOA-004-3
842,BRD-K36198571-001-01-2,metalloproteinase inhibitor,H-BIOA-004-3
843,BRD-K36258877-001-01-5,caspase inhibitor,H-BIOA-004-3
844,BRD-K36377456-001-02-0,angiogenesis inhibitor,H-BIOA-006-3
845,BRD-K36395411-003-01-4,serotonin receptor antagonist|serotonin receptor partial agonist,H-BIOA-006-3
846,BRD-K36638830-001-02-2,acetylcholine receptor agonist,H-BIOA-004-3
847,BRD-K36756879-003-04-6,calcium channel blocker,H-BIOA-004-3
848,BRD-K36862742-001-04-1,sodium/potassium/chloride transporter inhibitor,H-BIOA-004-3
849,BRD-K36864847-303-01-7,Adrenergic receptor antagonist,H-BIOA-004-3
850,BRD-K36927236-001-06-0,Sulfonylurea,H-BIOA-004-3
851,BRD-K36965586-001-01-7,serotonin receptor agonist,H-BIOA-004-3
852,BRD-K37249724-001-04-2,histamine receptor antagonist,H-BIOA-004-3
853,BRD-K37270826-001-03-7,glucocorticoid receptor antagonist|progesterone receptor antagonist,H-BIOA-004-3
854,BRD-K37289225-001-07-5,Dopamine receptor antagonist,H-BIOA-004-3
855,BRD-K37312348-001-05-1,CDK inhibitor|glycogen synthase kinase inhibitor,H-BIOA-006-3
856,BRD-K37392901-003-01-7,ubiquitin hydrolase inhibitor|ubiquitin isopeptidase inhibitor,H-BIOA-004-3
857,BRD-K37447567-001-01-8,Opioid receptor antagonist,H-BIOA-004-3
858,BRD-K37561857-001-04-9,phosphodiesterase inhibitor,H-BIOA-004-3
859,BRD-K37618799-001-01-4,adenosine receptor antagonist,H-BIOA-004-3
860,BRD-K37682401-001-05-1,bacterial DNA gyrase inhibitor,H-BIOA-004-3
861,BRD-K37688416-003-04-0,psychoactive drug,H-BIOA-004-3
862,BRD-K37691127-001-02-2,tyrosinase inhibitor,H-BIOA-004-3
863,BRD-K37792168-001-01-0,Phosphodiesterase inhibitor,H-BIOA-004-3
864,BRD-K37798499-001-02-5,topoisomerase inhibitor,H-BIOA-004-3
865,BRD-K37848908-001-03-1,penicillin binding protein inhibitor,H-BIOA-004-3
866,BRD-K37865504-001-01-7,FAAH inhibitor|FAAH reuptake inhibitor,H-BIOA-004-3
867,BRD-K37991163-050-05-1,selective serotonin reuptake inhibitor (SSRI),H-BIOA-004-3
868,BRD-K38003476-001-03-4,steroid,H-BIOA-004-3
869,BRD-K38055836-001-03-9,respiratory stimulant,H-BIOA-004-3
870,BRD-K38197229-001-06-7,solute carrier family member inhibitor,H-BIOA-004-3
871,BRD-K38251852-001-02-5,ABC transporter expression enhancer|high conductance calcium activated potassium blocker|LXR agonist|potassium channel blocker,H-BIOA-004-3
872,BRD-K38305202-001-01-8,dopamine receptor antagonist,H-BIOA-004-3
873,BRD-K38323065-001-05-8,cyclooxygenase inhibitor,H-BIOA-004-3
874,BRD-K38347298-001-02-3,adenosine receptor antagonist,H-BIOA-004-3
875,BRD-K38436528-003-04-8,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,H-BIOA-004-3
876,BRD-K38449220-001-03-8,cytochrome P450 inhibitor,H-BIOA-004-3
877,BRD-K38477985-001-01-8,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,H-BIOA-004-3
878,BRD-K38684403-001-02-1,bacterial 50S ribosomal subunit inhibitor,H-BIOA-004-3
879,BRD-K38775274-001-02-3,glucocorticoid receptor agonist,H-BIOA-004-3
880,BRD-K38903228-001-02-8,flavanone glycoside,H-BIOA-004-3
881,BRD-K39120595-304-02-1,autotaxin inhibitor,H-BIOA-004-3
882,BRD-K39187410-001-01-7,antiamyloidogenic agent,H-BIOA-004-3
883,BRD-K39188321-001-03-9,glucocorticoid receptor agonist,H-BIOA-004-3
884,BRD-K39339537-001-03-8,cyclooxygenase inhibitor,H-BIOA-004-3
885,BRD-K39356024-001-02-4,acetylcholine release enhancer|dopamine release enhancer|GABA receptor negative allosteric modulator|glutamate receptor modulator|progesterone receptor agonist|steroid hormone inhibitor of CYP17A1 and SULT2B1,H-BIOA-004-3
886,BRD-K39484304-001-02-5,RNA polymerase inhibitor,H-BIOA-004-3
887,BRD-K39670393-303-01-3,histamine receptor agonist,H-BIOA-004-3
888,BRD-K39733634-001-01-8,prostanoid receptor antagonist|angiotensin receptor antagonist,H-BIOA-004-3
889,BRD-K39746403-084-02-3,NFkB pathway inhibitor|50S ribosomal subunit inhibitor|motilin receptor agonist|RPLV inhibitor,H-BIOA-004-3
890,BRD-K39915878-036-04-6,dopamine receptor antagonist|serotonin receptor antagonist,H-BIOA-004-3
891,BRD-K39965020-001-02-6,PPAR receptor agonist,H-BIOA-004-3
892,BRD-K39987650-001-04-3,laxative,H-BIOA-004-3
893,BRD-K40255344-001-05-1,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,H-BIOA-004-3
894,BRD-K40530731-001-02-5,acetylcholine receptor inhibitor,H-BIOA-004-3
895,BRD-K40578143-001-01-8,adenosine receptor agonist,H-BIOA-004-3
896,BRD-K40656405-001-01-5,PPAR receptor agonist,H-BIOA-004-3
897,BRD-K40742111-001-02-6,lipoxygenase inhibitor,H-BIOA-004-3
898,BRD-K40782193-003-01-1,sodium channel blocker,H-BIOA-005-3
899,BRD-K40887525-001-02-9,serotonin receptor antagonist,H-BIOA-005-3
900,BRD-K40901640-001-01-0,serotonin receptor antagonist,H-BIOA-005-3
901,BRD-K40905133-001-02-3,sodium channel blocker,H-BIOA-005-3
902,BRD-K40965114-001-01-2,Adrenergic receptor antagonist,H-BIOA-005-3
903,BRD-K40990712-001-02-4,gonadotropin releasing factor hormone receptor antagonist|sodium/hydrogen antiport inhibitor|sodium/hydrogen exchanger inhibitor|urokinase inhibitor,H-BIOA-005-3
904,BRD-K41143549-003-01-6,glutamate receptor antagonist,H-BIOA-005-3
905,BRD-K41160163-001-01-9,Glutamate receptor antagonist,H-BIOA-006-3
906,BRD-K41337261-001-01-4,Src and Abl inhibitor|vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor,H-BIOA-005-3
907,BRD-K41406082-001-04-8,PABA antagonist,H-BIOA-005-3
908,BRD-K41445866-001-03-0,Chloride channel agonist,H-BIOA-005-3
909,BRD-K41524689-001-05-2,cyclooxygenase inhibitor,H-BIOA-005-3
910,BRD-K41564320-001-01-2,tyrosine kinase inhibitor,H-BIOA-005-3
911,BRD-K41567364-001-01-2,orexin receptor antagonist,H-BIOA-005-3
912,BRD-K41707108-001-02-3,Phosphoenolpyruvate carboxylase activator,H-BIOA-005-3
913,BRD-K41713976-001-02-0,potassium channel blocker,H-BIOA-005-3
914,BRD-K41868777-003-02-9,calmodulin antagonist,H-BIOA-005-3
915,BRD-K41876534-001-02-0,carbonic anhydrase inhibitor,H-BIOA-005-3
916,BRD-K41996876-001-05-5,EGFR inhibitor,H-BIOA-005-3
917,BRD-K42095107-001-02-3,estrogen receptor agonist,H-BIOA-006-3
918,BRD-K42098891-003-03-1,tricyclic antidepressant,H-BIOA-005-3
919,BRD-K42221274-001-01-4,GAT inhibitor,H-BIOA-005-3
920,BRD-K42348709-003-04-0,adrenergic receptor agonist|serotonin receptor agonist,H-BIOA-005-3
921,BRD-K42452249-001-01-7,p38 MAPK inhibitor,H-BIOA-005-3
922,BRD-K42500029-001-01-9,"MAP kinase inhibitor|MAPK-interacting kinase inhibitor,",H-BIOA-005-3
923,BRD-K42635745-001-02-4,adrenergic receptor antagonist,H-BIOA-005-3
924,BRD-K42679050-001-01-3,potassium channel activator|potassium channel agonist,H-BIOA-005-3
925,BRD-K42748308-300-01-2,acetylcholine release enhancer|potassium channel blocker|voltage-gated potassium channel blocker,H-BIOA-005-3
926,BRD-K43068349-001-01-9,TRPV antagonist,H-BIOA-005-3
927,BRD-K43149758-001-04-5,Androgen receptor agonist,H-BIOA-005-3
928,BRD-K43245338-001-02-4,calpain inhibitor|cathepsin inhibitor,H-BIOA-005-3
929,BRD-K43290182-001-01-9,Serotonin receptor antagonist,H-BIOA-005-3
930,BRD-K43330982-001-01-5,lysophospholipid receptor antagonist,H-BIOA-005-3
931,BRD-K43389675-003-02-7,RNA synthesis inhibitor|topoisomerase inhibitor,H-BIOA-005-3
932,BRD-K43405658-001-01-8,protein tyrosine kinase inhibitor,H-BIOA-005-3
933,BRD-K43457670-001-04-7,carbonic anhydrase inhibitor,H-BIOA-005-3
934,BRD-K43468059-001-02-9,Mycotoxin,H-BIOA-005-3
935,BRD-K43736954-001-03-3,glucocorticoid receptor agonist,H-BIOA-005-3
936,BRD-K43744935-048-01-6,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)|estrogen receptor agonist|estrogen receptor modulator|PKC inhibitor,H-BIOA-005-3
937,BRD-K43796186-001-01-1,EGFR inhibitor,H-BIOA-005-3
938,BRD-K43797669-001-02-3,tyrosine kinase inhibitor,H-BIOA-006-3
939,BRD-K43860855-065-03-6,antineoplastic agent,H-BIOA-005-3
940,BRD-K44067360-001-06-3,chloride channel blocker,H-BIOA-005-3
941,BRD-K44084986-001-03-9,rho associated kinase inhibitor,H-BIOA-005-3
942,BRD-K44849676-001-03-0,TRPV agonist,H-BIOA-005-3
943,BRD-K44876623-001-01-1,Benzodiazepine receptor agonist,H-BIOA-005-3
944,BRD-K44899736-003-02-1,Monoamine oxidase inhibitor,H-BIOA-005-3
945,BRD-K45033733-001-02-3,DNA polymerase inhibitor,H-BIOA-005-3
946,BRD-K45068323-003-01-3,Calmodulin antagonist,H-BIOA-005-3
947,BRD-K45117373-001-01-1,potassium channel activator|potassium channel agonist,H-BIOA-005-3
948,BRD-K45158365-001-02-3,angiotensin receptor antagonist,H-BIOA-005-3
949,BRD-K45296539-003-01-0,Adrenergic receptor agonist,H-BIOA-005-3
950,BRD-K45330754-001-04-3,estrogen receptor agonist,H-BIOA-005-3
951,BRD-K45401373-001-05-0,Apoptosis stimulant,H-BIOA-005-3
952,BRD-K45435259-001-01-6,Dopamine receptor antagonist,H-BIOA-005-3
953,BRD-K45479396-001-01-8,Serotonin receptor agonist,H-BIOA-005-3
954,BRD-K45542189-048-04-9,Lipoxygenase inhibitor,H-BIOA-005-3
955,BRD-K45662124-001-01-8,dopamine receptor ligand,H-BIOA-005-3
956,BRD-K45861246-001-04-3,Dopamine receptor antagonist,H-BIOA-005-3
957,BRD-K45988865-001-01-0,organosilicon compound used as an internal standard in NMR spectroscopy,H-BIOA-006-3
958,BRD-K46018455-001-06-0,PPAR receptor agonist,H-BIOA-005-3
959,BRD-K46137903-001-03-3,phospholipase activator,H-BIOA-005-3
960,BRD-K46142322-003-01-6,serotonin receptor partial agonist,H-BIOA-005-3
961,BRD-K46211610-003-05-1,Adrenergic receptor antagonist,H-BIOA-005-3
962,BRD-K46317332-003-04-6,Nitric oxide synthase inhibitor,H-BIOA-005-3
963,BRD-K46384212-001-01-1,phospholipase activator,H-BIOA-005-3
964,BRD-K46424862-001-04-2,Monoamine oxidase inhibitor,H-BIOA-005-3
965,BRD-K46435977-003-01-2,DNA polymerase inhibitor,H-BIOA-005-3
966,BRD-K46441700-001-01-8,serotonin receptor antagonist,H-BIOA-005-3
967,BRD-K46469693-001-01-8,adenosine receptor antagonist,H-BIOA-005-3
968,BRD-K46556543-237-03-0,Mineralocorticoid receptor antagonist,H-BIOA-005-3
969,BRD-K46678324-001-03-7,rho associated kinase inhibitor,H-BIOA-006-3
970,BRD-K46766488-003-01-2,Serotonin receptor agonist,H-BIOA-005-3
971,BRD-K46862739-001-03-6,cytochrome P450 inhibitor,H-BIOA-005-3
972,BRD-K46937689-001-05-1,Cyclooxygenase inhibitor,H-BIOA-005-3
973,BRD-K47105409-001-05-3,JAK inhibitor,H-BIOA-005-3
974,BRD-K47150025-001-01-2,PDGFR alpha and c-Kit inhibitor|vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor,H-BIOA-005-3
975,BRD-K47192521-001-02-1,Platelet aggregation inhibitor,H-BIOA-005-3
976,BRD-K47207162-312-02-2,Serotonin reuptake inhibitor,H-BIOA-005-3
977,BRD-K47278471-003-04-0,Histamine receptor antagonist,H-BIOA-005-3
978,BRD-K47323024-003-04-6,Histamine receptor antagonist,H-BIOA-005-3
979,BRD-K47328134-001-02-0,heparin activation inhibitor,H-BIOA-005-3
980,BRD-K47598052-001-04-2,src inhibitor,H-BIOA-005-3
981,BRD-K47608922-001-02-1,chelating agent,H-BIOA-005-3
982,BRD-K47631482-003-02-1,Mucolytic agent,H-BIOA-005-3
983,BRD-K47635719-001-03-9,glucocorticoid receptor agonist,H-BIOA-005-3
984,BRD-K47639036-003-03-3,Acetylcholine receptor antagonist,H-BIOA-005-3
985,BRD-K47659338-003-01-0,serotonin receptor agonist,H-BIOA-005-3
986,BRD-K47693913-001-02-4,Furoquinoline alkaloid,H-BIOA-005-3
987,BRD-K47717570-304-01-5,Glutamate receptor antagonist,H-BIOA-005-3
988,BRD-K47869605-001-04-9,microtubule inhibitor|tubulin polymerization inhibitor,H-BIOA-005-3
989,BRD-K47936004-001-01-9,dopamine receptor agonist,H-BIOA-005-3
990,BRD-K47943470-001-02-8,EGFR inhibitor,H-BIOA-005-3
991,BRD-K48168960-001-05-1,Thyroid peroxidase inhibitor,H-BIOA-005-3
992,BRD-K48300629-001-03-8,Sodium channel blocker,H-BIOA-005-3
993,BRD-K48692744-001-01-2,PARP inhibitor,H-BIOA-005-3
994,BRD-K48722258-300-04-5,adenosine reuptake inhibitor,H-BIOA-005-3
995,BRD-K48735772-001-01-4,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor,H-BIOA-005-3
996,BRD-K49027941-237-01-1,Adenosine receptor antagonist,H-BIOA-005-3
997,BRD-K49049886-001-03-8,adenosine receptor antagonist,H-BIOA-005-3
998,BRD-K49061529-001-01-0,GABA benzodiazepine site receptor inverse agonist,H-BIOA-006-3
999,BRD-K49111258-001-02-8,Adrenergic receptor antagonist,H-BIOA-005-3
1000,BRD-K49294207-300-01-2,EGFR inhibitor,H-BIOA-005-3
1001,BRD-K49448285-001-01-3,CDK inhibitor,H-BIOA-005-3
1002,BRD-K49481516-004-03-5,Acetylcholinesterase inhibitor,H-BIOA-005-3
1003,BRD-K49519092-303-01-4,Histamine receptor agonist,H-BIOA-005-3
1004,BRD-K49577446-001-03-1,cytochrome P450 inhibitor,H-BIOA-005-3
1005,BRD-K49657628-001-02-3,EGFR inhibitor|tyrosine kinase inhibitor,H-BIOA-005-3
1006,BRD-K49671696-001-02-1,Serotonin receptor antagonist,H-BIOA-005-3
1007,BRD-K49890030-236-01-6,Glutamate receptor antagonist,H-BIOA-005-3
1008,BRD-K49945136-001-03-5,Serotonin receptor antagonist,H-BIOA-005-3
1009,BRD-K50018155-003-01-3,Serotonin receptor partial agonist,H-BIOA-005-3
1010,BRD-K50135270-001-01-9,dopamine uptake inhibitor,H-BIOA-005-3
1011,BRD-K50214219-001-02-4,PARP inhibitor,H-BIOA-005-3
1012,BRD-K50325075-001-01-3,potassium channel blocker|slow afterhyperpolarization channel blocker,H-BIOA-005-3
1013,BRD-K50388907-001-04-9,PPAR receptor agonist,H-BIOA-005-3
1014,BRD-K50398167-236-02-9,Cyclooxygenase inhibitor,H-BIOA-005-3
1015,BRD-K50417881-003-05-9,Dopamine receptor antagonist,H-BIOA-005-3
1016,BRD-K50422030-001-01-2,GABA receptor antagonist,H-BIOA-005-3
1017,BRD-K50464341-001-02-6,calmodulin antagonist,H-BIOA-005-3
1018,BRD-K50495309-001-01-2,src inhibitor,H-BIOA-005-3
1019,BRD-K50660797-001-02-8,Bacterial DNA gyrase inhibitor,H-BIOA-005-3
1020,BRD-K50836978-001-01-7,CDK inhibitor,H-BIOA-005-3
1021,BRD-K50841342-001-01-6,caspase activator,H-BIOA-005-3
1022,BRD-K50859149-001-04-7,bacterial antifolate,H-BIOA-005-3
1023,BRD-K50891186-001-01-0,dopamine receptor antagonist,H-BIOA-005-3
1024,BRD-K51276371-001-01-8,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor,H-BIOA-005-3
1025,BRD-K51318897-001-04-7,tubulin polymerization inhibitor,H-BIOA-005-3
1026,BRD-K51465424-003-03-6,adrenergic receptor agonist,H-BIOA-005-3
1027,BRD-K51476772-001-01-9,tyrosine kinase inhibitor,H-BIOA-005-3
1028,BRD-K51541829-001-01-3,Ionotropic glutamate receptor antagonist,H-BIOA-005-3
1029,BRD-K51575138-001-01-7,IKK inhibitor,H-BIOA-005-3
1030,BRD-K51671335-001-01-5,Dopamine receptor antagonist,H-BIOA-005-3
1031,BRD-K51751936-001-03-4,benzodiazepine receptor agonist,H-BIOA-005-3
1032,BRD-K51918615-303-01-1,histamine receptor antagonist|histamine receptor inhibitor|ionotropic glutamate receptor antagonist,H-BIOA-005-3
1033,BRD-K52020312-001-04-5,DNA inhibitor,H-BIOA-005-3
1034,BRD-K52075040-001-02-2,fatty acid synthase inhibitor,H-BIOA-005-3
1035,BRD-K52219182-001-01-6,Phosphodiesterase inhibitor,H-BIOA-005-3
1036,BRD-K52313696-001-01-6,HDAC inhibitor,H-BIOA-005-3
1037,BRD-K52394958-001-01-9,tachykinin antagonist,H-BIOA-005-3
1038,BRD-K52397688-001-01-9,dopamine receptor antagonist|FAAH inhibitor|serotonin receptor antagonist,H-BIOA-005-3
1039,BRD-K52459643-001-10-2,Prostanoid receptor agonist,H-BIOA-005-3
1040,BRD-K52512893-001-03-0,Prostanoid receptor antagonist,H-BIOA-005-3
1041,BRD-K52620403-001-01-8,calcium/calmodulin dependent protein kinase inhibitor|calmodulin inhibitor,H-BIOA-006-3
1042,BRD-K52662033-001-02-6,histamine receptor agonist,H-BIOA-005-3
1043,BRD-K52721684-001-02-2,potassium channel activator,H-BIOA-005-3
1044,BRD-K52850071-001-01-2,JAK inhibitor,H-BIOA-005-3
1045,BRD-K52930707-001-04-8,ACE inhibitor,H-BIOA-005-3
1046,BRD-K52989797-001-01-1,serotonin transporter (SERT) inhibitor,H-BIOA-005-3
1047,BRD-K53123955-001-03-0,Phosphofructokinase inhibitor,H-BIOA-005-3
1048,BRD-K53263234-001-02-9,constitutive androstane receptor (CAR) agonist,H-BIOA-005-3
1049,BRD-K53318339-001-04-1,Phosphodiesterase inhibitor,H-BIOA-005-3
1050,BRD-K53523901-001-01-0,adiponectin receptor agonist|AP inhibitor|aryl hydrocarbon receptor antagonist|HIV integrase inhibitor|MEK inhibitor|NFkB pathway inhibitor|topoisomerase inhibitor,H-BIOA-005-3
1051,BRD-K53545112-304-01-6,Glutamate receptor antagonist,H-BIOA-005-3
1052,BRD-K53737926-003-04-7,Norepinephrine inhibitor,H-BIOA-005-3
1053,BRD-K53857191-001-04-5,Dopamine receptor antagonist,H-BIOA-005-3
1054,BRD-K53878242-001-02-4,phosphodiesterase inhibitor,H-BIOA-005-3
1055,BRD-K53979406-003-01-0,glycine transporter inhibitor|GlyT-1 inhibitor,H-BIOA-005-3
1056,BRD-K54094468-001-01-6,dopamine receptor antagonist,H-BIOA-005-3
1057,BRD-K54095730-001-01-5,p38 MAPK inhibitor,H-BIOA-005-3
1058,BRD-K54142781-001-02-1,Adrenergic receptor agonist,H-BIOA-005-3
1059,BRD-K54210043-001-02-0,calcium channel activator|large conductance potassium channel activator,H-BIOA-005-3
1060,BRD-K54233340-300-01-0,AMPK inhibitor|DNA damaging|TGF beta receptor inhibitor,H-BIOA-005-3
1061,BRD-K54330070-001-05-5,p38 MAPK inhibitor,H-BIOA-005-3
1062,BRD-K54411430-001-02-5,cAMP inhibitor,H-BIOA-005-3
1063,BRD-K54529596-001-04-0,ACE inhibitor,H-BIOA-005-3
1064,BRD-K54665485-001-01-2,Diacylglycerol kinase inhibitor,H-BIOA-005-3
1065,BRD-K54704028-001-01-3,glutamate receptor antagonist,H-BIOA-005-3
1066,BRD-K54708045-001-01-3,PPAR receptor agonist,H-BIOA-005-3
1067,BRD-K54759182-003-02-3,Norepinephrine reuptake inhibitor,H-BIOA-005-3
1068,BRD-K54771420-001-03-2,Cholesterol inhibitor,H-BIOA-005-3
1069,BRD-K54790157-001-03-1,DNA synthesis inhibitor,H-BIOA-005-3
1070,BRD-K55034111-066-02-3,bacterial DNA gyrase inhibitor,H-BIOA-005-3
1071,BRD-K55191674-236-03-7,Penicillin binding protein inhibitor,H-BIOA-005-3
1072,BRD-K55344148-003-01-8,Imidazoline receptor ligand,H-BIOA-005-3
1073,BRD-K55424922-001-01-4,Serotonin receptor agonist,H-BIOA-005-3
1074,BRD-K55430733-003-01-6,Serotonin receptor agonist,H-BIOA-005-3
1075,BRD-K55454768-001-01-8,voltage-independent calcium influx blocker,H-BIOA-005-3
1076,BRD-K55468218-001-04-8,dopamine receptor antagonist,H-BIOA-005-3
1077,BRD-K55529781-236-02-0,thromboxane synthase inhibitor,H-BIOA-005-3
1078,BRD-K55567017-001-02-4,alcohol dehydrogenase inhibitor,H-BIOA-005-3
1079,BRD-K55677650-003-01-1,ionotropic glutamate receptor antagonist,H-BIOA-005-3
1080,BRD-K55748775-001-01-4,ATPase inhibitor|potassium-competitive acid antagonist,H-BIOA-005-3
1081,BRD-K55930204-001-02-7,Hydantoin antiepileptic,H-BIOA-005-3
1082,BRD-K56047318-001-02-2,Triacylglycerol lipase inhibitor,H-BIOA-005-3
1083,BRD-K56064827-001-04-7,PKC inhibitor,H-BIOA-005-3
1084,BRD-K56115039-003-01-3,Imidazoline receptor ligand,H-BIOA-005-3
1085,BRD-K56403959-300-01-9,CC chemokine receptor ligand,H-BIOA-005-3
1086,BRD-K56429665-001-03-9,vitamin D receptor agonist,H-BIOA-005-3
1087,BRD-K56509348-003-01-3,Endothelin receptor antagonist,H-BIOA-005-3
1088,BRD-K56558538-003-02-8,Sodium channel blocker,H-BIOA-005-3
1089,BRD-K56596464-004-02-4,Sodium channel blocker,H-BIOA-005-3
1090,BRD-K56699285-001-03-7,dopamine receptor agonist|serotonin receptor antagonist,H-BIOA-005-3
1091,BRD-K57033106-048-02-8,Histamine receptor antagonist,H-BIOA-005-3
1092,BRD-K57179821-001-04-8,Antipruritic,H-BIOA-005-3
1093,BRD-K57222227-001-06-1,cyclooxygenase inhibitor,H-BIOA-005-3
1094,BRD-K57304726-003-03-6,Sigma receptor agonist,H-BIOA-005-3
1095,BRD-K57545991-050-03-3,angiotensin converting enzyme inhibitor,H-BIOA-005-3
1096,BRD-K57569181-001-04-4,Phosphodiesterase inhibitor,H-BIOA-005-3
1097,BRD-K57718010-001-06-9,GABA receptor antagonist,H-BIOA-005-3
1098,BRD-K57886322-001-03-4,glucocorticoid receptor agonist,H-BIOA-005-3
1099,BRD-K57926513-001-02-9,PDGFR receptor inhibitor,H-BIOA-005-3
1100,BRD-K58220566-001-02-2,PKC inhibitor|sodium channel blocker|calcium channel blocker,H-BIOA-005-3
1101,BRD-K58265391-001-03-6,diuretic,H-BIOA-005-3
1102,BRD-K58299615-001-02-7,amyloid precursor protein inhibitor|beta amyloid aggregation inhibitor,H-BIOA-005-3
1103,BRD-K58466253-003-04-1,serotonin release inhibitor,H-BIOA-005-3
1104,BRD-K58685305-001-02-2,11-beta hydroxysteroid dehydrogenase inhibitor,H-BIOA-005-3
1105,BRD-K58930050-001-01-1,glutamate receptor antagonist,H-BIOA-005-3
1106,BRD-K58938839-001-03-8,smoothened receptor antagonist|hedgehog pathway inhibitor,H-BIOA-005-3
1107,BRD-K59037100-001-04-8,lipase inhibitor,H-BIOA-005-3
1108,BRD-K59058766-003-03-7,dopamine receptor antagonist,H-BIOA-005-3
1109,BRD-K59184148-001-04-2,glycogen synthase kinase inhibitor,H-BIOA-005-3
1110,BRD-K59273480-001-01-5,adenosine reuptake inhibitor|phosphodiesterase inhibitor,H-BIOA-005-3
1111,BRD-K59331372-001-01-2,TRPV antagonist,H-BIOA-006-3
1112,BRD-K59332007-300-01-9,acetylcholine release enhancer|acetylcholine release stimulant|neurotransmitter agonist|voltage-gated potassium channel blocker,H-BIOA-005-3
1113,BRD-K59419204-001-01-9,cannabinoid receptor antagonist|cannabinoid receptor inhibitor,H-BIOA-005-3
1114,BRD-K59469039-001-04-9,Angiogenesis inhibitor,H-BIOA-005-3
1115,BRD-K59522102-001-04-7,monoamine oxidase inhibitor,H-BIOA-005-3
1116,BRD-K59574735-001-02-7,leukotriene synthesis inhibitor,H-BIOA-005-3
1117,BRD-K59637651-001-01-4,protein synthesis inhibitor|botulin neurotoxin inhibitor|mur synthetase inhibitor,H-BIOA-005-3
1118,BRD-K59650319-003-01-7,glutamate receptor antagonist,H-BIOA-005-3
1119,BRD-K59753853-001-01-5,glutamate receptor antagonist,H-BIOA-005-3
1120,BRD-K59851896-001-02-4,GABA release inhibitor,H-BIOA-005-3
1121,BRD-K59983611-001-05-2,bacterial antifolate,H-BIOA-005-3
1122,BRD-K60060639-005-01-4,antiarrhythmic medication,H-BIOA-005-3
1123,BRD-K60174629-001-02-2,prolyl endopeptidase inhibitor,H-BIOA-005-3
1124,BRD-K60184833-001-02-3,tyrosine kinase inhibitor,H-BIOA-005-3
1125,BRD-K60230970-001-04-3,proteasome inhibitor,H-BIOA-005-3
1126,BRD-K60274257-001-01-1,tyrosine phosphatase inhibitor,H-BIOA-005-3
1127,BRD-K60298136-001-01-7,aryl hydrocarbon receptor agonist|aryl hydrocarbon receptor ligand,H-BIOA-005-3
1128,BRD-K60476892-001-02-1,activator of soluble guanylyl cyclase|guanylate cyclase activator|hypoxia inducible factor inhibitor,H-BIOA-005-3
1129,BRD-K60511616-236-01-4,HMGCR inhibitor,H-BIOA-005-3
1130,BRD-K60640630-001-03-7,glucocorticoid receptor agonist,H-BIOA-005-3
1131,BRD-K60690191-003-02-1,glutamate receptor antagonist,H-BIOA-006-3
1132,BRD-K60923938-001-02-8,sodium channel activator,H-BIOA-005-3
1133,BRD-K60932973-001-01-7,dopamine receptor agonist,H-BIOA-005-3
1134,BRD-K61097567-001-03-6,tachykinin antagonist,H-BIOA-005-3
1135,BRD-K61177364-003-01-1,CRF receptor antagonist,H-BIOA-006-3
1136,BRD-K61250553-001-02-9,opioid receptor agonist,H-BIOA-006-3
1137,BRD-K61269089-001-01-4,Protein kinase inhibitor,H-BIOA-006-3
1138,BRD-K61271364-001-02-4,GABA receptor antagonist,H-BIOA-006-3
1139,BRD-K61323504-001-02-4,CC chemokine receptor antagonist,H-BIOA-006-3
1140,BRD-K61496577-001-03-8,glucocorticoid receptor agonist,H-BIOA-006-3
1141,BRD-K61590534-001-01-4,EGFR inhibitor,H-BIOA-006-3
1142,BRD-K61737877-001-01-6,VEGFR inhibitor,H-BIOA-006-3
1143,BRD-K61951118-001-01-2,GABA benzodiazepine site receptor inverse agonist,H-BIOA-006-3
1144,BRD-K62008436-001-03-1,tubulin polymerization inhibitor,H-BIOA-006-3
1145,BRD-K62056274-001-01-9,Serotonin receptor agonist,H-BIOA-006-3
1146,BRD-K62206109-303-01-1,histamine receptor antagonist,H-BIOA-006-3
1147,BRD-K62221994-001-01-8,gonadotropin releasing factor hormone receptor antagonist,H-BIOA-006-3
1148,BRD-K62289640-003-01-9,Cannabinoid receptor agonist,H-BIOA-006-3
1149,BRD-K62310379-001-03-0,glucocorticoid receptor agonist,H-BIOA-006-3
1150,BRD-K62353524-001-01-8,estrogen receptor agonist,H-BIOA-006-3
1151,BRD-K62363391-001-04-1,bacterial antifolate,H-BIOA-006-3
1152,BRD-K62607865-001-03-0,bacterial cell wall synthesis inhibitor,H-BIOA-006-3
1153,BRD-K62609077-001-02-2,adrenergic receptor antagonist|GABA receptor antagonist|serotonin receptor antagonist,H-BIOA-006-3
1154,BRD-K62810658-001-05-6,MEK inhibitor,H-BIOA-006-3
1155,BRD-K62929068-001-01-7,Purinergic receptor activator,H-BIOA-006-3
1156,BRD-K62996583-001-03-8,calcium channel blocker,H-BIOA-006-3
1157,BRD-K63089472-001-02-7,Inhibitor of methyl esterification of farnesylated proteins,H-BIOA-006-3
1158,BRD-K63150726-001-01-3,cannabinoid receptor inverse agonist,H-BIOA-006-3
1159,BRD-K63151507-001-01-6,Lymphocyte inhibitor,H-BIOA-006-3
1160,BRD-K63165456-001-03-3,Adrenergic receptor agonist,H-BIOA-006-3
1161,BRD-K63430059-001-03-2,DNA synthesis inhibitor,H-BIOA-006-3
1162,BRD-K63504947-001-05-5,VEGFR inhibitor,H-BIOA-006-3
1163,BRD-K63516691-001-01-6,Phosphodiesterase inhibitor,H-BIOA-006-3
1164,BRD-K63533170-001-01-1,cannabinoid receptor antagonist|cannabinoid receptor inverse agonist,H-BIOA-006-3
1165,BRD-K63606607-001-01-8,ATPase inhibitor|chloride channel activator,H-BIOA-006-3
1166,BRD-K63630713-001-04-3,sodium/potassium/chloride transporter inhibitor,H-BIOA-006-3
1167,BRD-K63750851-001-03-3,dehydrogenase inhibitor|inositol monophosphatase inhibitor,H-BIOA-006-3
1168,BRD-K63784565-001-02-1,Topoisomerase inhibitor,H-BIOA-006-3
1169,BRD-K63792901-075-01-3,acetylcholine receptor agonist,H-BIOA-006-3
1170,BRD-K63828191-003-07-3,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),H-BIOA-006-3
1171,BRD-K63874012-103-01-5,histamine receptor antagonist|histamine receptor inverse agonist,H-BIOA-006-3
1172,BRD-K63913457-001-02-7,vasodilator,H-BIOA-006-3
1173,BRD-K63945320-001-02-4,Phospholipase inhibitor,H-BIOA-006-3
1174,BRD-K63979671-001-03-6,Compound used in hepatobiliary scans of the liver,H-BIOA-006-3
1175,BRD-K64044582-001-02-8,ACAT inhibitor,H-BIOA-006-3
1176,BRD-K64157027-003-01-9,Adrenergic receptor agonist,H-BIOA-006-3
1177,BRD-K64245000-001-01-7,FXR agonist,H-BIOA-006-3
1178,BRD-K64341947-003-01-6,guanylate cyclase activator,H-BIOA-006-3
1179,BRD-K64402243-001-01-1,Caspase inhibitor,H-BIOA-006-3
1180,BRD-K64670467-001-01-2,glutamate receptor antagonist,H-BIOA-006-3
1181,BRD-K64755930-003-01-6,phosphodiesterase inhibitor,H-BIOA-006-3
1182,BRD-K64862097-001-03-9,glucocorticoid receptor agonist,H-BIOA-006-3
1183,BRD-K64994968-001-03-6,Progesterone receptor agonist,H-BIOA-006-3
1184,BRD-K65146499-001-04-8,Cyclooxygenase inhibitor,H-BIOA-006-3
1185,BRD-K65285700-001-01-5,cannabinoid receptor agonist,H-BIOA-006-3
1186,BRD-K65417056-003-03-6,Local anesthetic,H-BIOA-006-3
1187,BRD-K65503129-001-01-4,HSP inhibitor|HSP antagonist,H-BIOA-006-3
1188,BRD-K65639003-001-02-5,phosphodiesterase inhibitor,H-BIOA-006-3
1189,BRD-K65667145-001-04-1,cell division inducer,H-BIOA-006-3
1190,BRD-K65786282-001-02-6,GABA receptor modulator,H-BIOA-006-3
1191,BRD-K65814004-001-02-3,nitric oxide synthase inhibitor|aldehyde dehydrogenase inhibitor|cytochrome P450 inhibitor|NADPH oxidase inhibitor|xanthine oxidase inhibitor,H-BIOA-006-3
1192,BRD-K66093087-001-01-5,Benzodiazepine receptor agonist,H-BIOA-006-3
1193,BRD-K66206289-003-03-1,Acetylcholine receptor antagonist,H-BIOA-006-3
1194,BRD-K66353228-001-05-4,myorelaxant,H-BIOA-006-3
1195,BRD-K66404838-003-03-8,opioid receptor agonist|opioid receptor antagonist,H-BIOA-006-3
1196,BRD-K66707493-001-02-6,Coloring agent,H-BIOA-006-3
1197,BRD-K66715657-001-01-3,dopamine receptor antagonist,H-BIOA-006-3
1198,BRD-K66782112-001-01-2,Histamine receptor antagonist,H-BIOA-006-3
1199,BRD-K66874953-001-02-7,TP53 inhibitor,H-BIOA-006-3
1200,BRD-K66898851-001-03-7,apoptosis stimulant,H-BIOA-006-3
1201,BRD-K66944906-001-02-6,Carbonic anhydrase inhibitor,H-BIOA-006-3
1202,BRD-K67013324-001-01-5,melatonin receptor antagonist,H-BIOA-006-3
1203,BRD-K67017579-001-13-3,Phosphodiesterase inhibitor,H-BIOA-006-3
1204,BRD-K67043667-001-04-1,DNA synthesis inhibitor,H-BIOA-006-3
1205,BRD-K67080878-001-05-5,phosphodiesterase inhibitor,H-BIOA-006-3
1206,BRD-K67102207-236-01-0,HDAC inhibitor,H-BIOA-006-3
1207,BRD-K67261995-001-03-4,Contrast agent,H-BIOA-006-3
1208,BRD-K67277431-002-03-0,thromboxane receptor antagonist|thromboxane synthase inhibitor,H-BIOA-006-3
1209,BRD-K67298865-001-02-5,TGF beta receptor inhibitor,H-BIOA-006-3
1210,BRD-K67352070-364-01-5,Acetylcholine receptor agonist,H-BIOA-006-3
1211,BRD-K67439147-001-01-7,glutamate receptor antagonist,H-BIOA-006-3
1212,BRD-K67445247-001-01-3,Urease inhibitor,H-BIOA-006-3
1213,BRD-K67537649-001-01-1,insulin growth factor receptor inhibitor,H-BIOA-006-3
1214,BRD-K67680372-003-01-8,GAT inhibitor,H-BIOA-006-3
1215,BRD-K67783091-001-05-5,Dopamine receptor antagonist,H-BIOA-006-3
1216,BRD-K67831364-003-01-7,vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor|VEGFR inhibitor,H-BIOA-006-3
1217,BRD-K67860401-001-02-3,glycogen synthase kinase inhibitor,H-BIOA-006-3
1218,BRD-K68095457-001-04-4,Cannabinoid receptor agonist,H-BIOA-006-3
1219,BRD-K68103045-001-01-1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,H-BIOA-006-3
1220,BRD-K68143200-001-04-2,CDC inhibitor,H-BIOA-006-3
1221,BRD-K68190965-001-01-4,Serotonin receptor agonist,H-BIOA-006-3
1222,BRD-K68246049-001-01-4,Retinoid receptor agonist,H-BIOA-006-3
1223,BRD-K68264559-001-07-6,Adrenergic receptor agonist,H-BIOA-006-3
1224,BRD-K68332390-001-03-3,aldose reductase inhibitor|reductase inhibitor,H-BIOA-006-3
1225,BRD-K68336408-001-03-4,EGFR inhibitor,H-BIOA-006-3
1226,BRD-K68341547-003-01-6,calmodulin antagonist,H-BIOA-006-3
1227,BRD-K68392338-003-01-2,Benzodiazepine receptor antagonist,H-BIOA-006-3
1228,BRD-K68402494-001-04-7,myosin light chain kinase inhibitor,H-BIOA-006-3
1229,BRD-K68507560-003-04-8,acetylcholine receptor antagonist,H-BIOA-006-3
1230,BRD-K68552125-001-03-8,PKC activator|CD antagonist,H-BIOA-006-3
1231,BRD-K68553471-003-04-0,antihypertensive agent,H-BIOA-006-3
1232,BRD-K68558722-001-02-4,Cyclooxygenase inhibitor,H-BIOA-006-3
1233,BRD-K68620903-001-03-1,progesterone receptor agonist,H-BIOA-006-3
1234,BRD-K68873215-001-01-3,phosphodiesterase inhibitor,H-BIOA-006-3
1235,BRD-K69023402-001-02-5,ATPase inhibitor|calcium channel blocker|PKC activator,H-BIOA-006-3
1236,BRD-K69032158-001-02-2,Dipeptidyl peptidase inhibitor,H-BIOA-006-3
1237,BRD-K69195780-001-01-5,Serotonin receptor agonist,H-BIOA-006-3
1238,BRD-K69556541-001-02-6,Calcium channel blocker,H-BIOA-006-3
1239,BRD-K69763916-001-01-7,Glutamate receptor antagonist,H-BIOA-006-3
1240,BRD-K69837166-003-01-2,Nociceptin/orphanin FQ (NOP) receptor antagonist,H-BIOA-006-3
1241,BRD-K70241288-001-01-1,Growth hormone releasing peptide ligand agonist,H-BIOA-006-3
1242,BRD-K70246307-001-02-5,vitamin B2,H-BIOA-006-3
1243,BRD-K70281171-001-01-7,Dopamine receptor antagonist,H-BIOA-006-3
1244,BRD-K70330367-001-02-4,Glutamate receptor antagonist,H-BIOA-006-3
1245,BRD-K70487031-001-01-0,dopamine receptor antagonist,H-BIOA-006-3
1246,BRD-K70778732-003-04-4,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,H-BIOA-006-3
1247,BRD-K70792160-003-01-2,AKT inhibitor,H-BIOA-006-3
1248,BRD-K70881766-001-02-3,Acetylcholinesterase inhibitor,H-BIOA-006-3
1249,BRD-K70914287-300-01-0,EGFR inhibitor|tyrosine kinase inhibitor,H-BIOA-006-3
1250,BRD-K70976396-236-04-7,Bacterial cell wall synthesis inhibitor,H-BIOA-006-3
1251,BRD-K71003802-001-02-9,Plant alkaloid,H-BIOA-006-3
1252,BRD-K71266197-236-01-9,NTPDase inhibitor,H-BIOA-006-3
1253,BRD-K71430621-303-01-5,histamine receptor antagonist|histamine receptor inverse agonist,H-BIOA-006-3
1254,BRD-K71499074-001-03-8,Carbonic anhydrase inhibitor,H-BIOA-006-3
1255,BRD-K71534238-001-03-5,Free fatty acid receptor agonist,H-BIOA-006-3
1256,BRD-K71726959-001-05-9,CDK inhibitor,H-BIOA-006-3
1257,BRD-K71731651-001-01-9,Acetylcholine receptor agonist,H-BIOA-006-3
1258,BRD-K71799778-001-02-2,CDK inhibitor,H-BIOA-006-3
1259,BRD-K71799949-001-04-2,Carboxamide antiepileptic,H-BIOA-006-3
1260,BRD-K71860425-001-01-1,CDK inhibitor,H-BIOA-006-3
1261,BRD-K72024482-001-01-3,adenosine receptor antagonist,H-BIOA-006-3
1262,BRD-K72034655-001-02-1,apoptosis inducer|antileukemic,H-BIOA-006-3
1263,BRD-K72222507-003-02-8,ACE inhibitor,H-BIOA-006-3
1264,BRD-K72676686-103-01-8,selective serotonin reuptake inhibitor (SSRI)|serotonin reuptake inhibitor|serotonin uptake inhibitor,H-BIOA-006-3
1265,BRD-K72703948-001-01-0,Aurora kinase inhibitor,H-BIOA-006-3
1266,BRD-K72726508-001-01-3,CDK inhibitor,H-BIOA-006-3
1267,BRD-K72783841-001-01-0,CDK inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor|EGFR inhibitor,H-BIOA-006-3
1268,BRD-K72895815-001-01-4,leukocyte elastase inhibitor,H-BIOA-006-3
1269,BRD-K72903603-001-03-8,Reverse transcriptase inhibitor,H-BIOA-006-3
1270,BRD-K73109821-001-05-2,Potassium channel activator,H-BIOA-006-3
1271,BRD-K73196317-003-06-4,adrenergic receptor antagonist,H-BIOA-006-3
1272,BRD-K73290745-003-01-8,opioid receptor agonist,H-BIOA-006-3
1273,BRD-K73323637-003-03-4,adrenergic receptor antagonist,H-BIOA-006-3
1274,BRD-K73391359-003-03-7,Local anesthetic,H-BIOA-006-3
1275,BRD-K73397362-001-01-7,smoothened receptor agonist,H-BIOA-006-3
1276,BRD-K73589401-001-03-8,mineralocorticoid receptor agonist,H-BIOA-006-3
1277,BRD-K73789395-001-04-0,RAF inhibitor,H-BIOA-006-3
1278,BRD-K73991644-001-01-7,aldose reductase inhibitor|falcipain inhibitor,H-BIOA-006-3
1279,BRD-K74112339-001-02-7,Urease inhibitor,H-BIOA-006-3
1280,BRD-K74141488-003-03-9,Fungal squalene epoxidase inhibitor,H-BIOA-006-3
1281,BRD-K74195153-050-03-0,Phosphodiesterase inhibitor,H-BIOA-006-3
1282,BRD-K74212935-001-03-1,Dopamine agonist,H-BIOA-006-3
1283,BRD-K74305673-001-01-3,IKK inhibitor|NFkB pathway inhibitor|protein kinase inhibitor,H-BIOA-006-3
1284,BRD-K74430258-001-01-2,hepatotoxicant,H-BIOA-006-3
1285,BRD-K74765201-001-01-9,Leukotriene receptor antagonist,H-BIOA-006-3
1286,BRD-K74913225-001-03-3,Carbonic anhydrase inhibitor,H-BIOA-006-3
1287,BRD-K75089421-001-02-5,sodium channel blocker,H-BIOA-006-3
1288,BRD-K75181824-001-02-3,inhibitor of methyl esterification of geranylgeranylated proteins,H-BIOA-006-3
1289,BRD-K75478907-001-01-5,GABA receptor modulator|GABA receptor positive allosteric modulator,H-BIOA-006-3
1290,BRD-K75615183-001-01-7,Adrenergic receptor agonist,H-BIOA-006-3
1291,BRD-K75641298-001-01-5,Dopamine receptor antagonist,H-BIOA-006-3
1292,BRD-K75958195-001-01-7,serotonin receptor antagonist,H-BIOA-006-3
1293,BRD-K76064317-001-04-0,FLT3 inhibitor,H-BIOA-006-3
1294,BRD-K76133116-001-01-2,Membrane integrity inhibitor,H-BIOA-006-3
1295,BRD-K76274772-001-02-7,Ceramidase inhibitor,H-BIOA-006-3
1296,BRD-K76304753-003-04-7,local anesthetic,H-BIOA-006-3
1297,BRD-K76568384-001-01-4,estrogen receptor antagonist,H-BIOA-006-3
1298,BRD-K76587808-001-02-0,Antioxidant,H-BIOA-006-3
1299,BRD-K76617868-001-02-2,rho associated kinase inhibitor,H-BIOA-006-3
1300,BRD-K76634210-001-02-2,DNA directed DNA polymerase inhibitor,H-BIOA-006-3
1301,BRD-K76674262-001-01-7,apoptosis stimulant|protein synthesis inhibitor,H-BIOA-006-3
1302,BRD-K76723084-001-05-9,retinoid receptor agonist,H-BIOA-006-3
1303,BRD-K76775527-001-06-2,Cyclooxygenase inhibitor,H-BIOA-006-3
1304,BRD-K76805682-001-05-0,glycogen synthase kinase inhibitor,H-BIOA-006-3
1305,BRD-K76810206-001-05-7,adrenergic receptor antagonist,H-BIOA-006-3
1306,BRD-K76840893-003-01-7,adrenergic receptor antagonist,H-BIOA-006-3
1307,BRD-K76872913-001-02-8,Aromatic hydrocarbon derivative,H-BIOA-006-3
1308,BRD-K76927775-001-04-3,DNA inhibitor,H-BIOA-006-3
1309,BRD-K77133231-001-01-1,p38 MAPK inhibitor,H-BIOA-006-3
1310,BRD-K77171813-050-01-4,histamine receptor modulator,H-BIOA-006-3
1311,BRD-K77554836-001-03-3,glucocorticoid receptor agonist,H-BIOA-006-3
1312,BRD-K77641333-003-04-0,adrenergic receptor agonist,H-BIOA-006-3
1313,BRD-K77677632-003-01-8,serotonin receptor antagonist,H-BIOA-006-3
1314,BRD-K77695569-001-04-5,angiogenesis inhibitor,H-BIOA-006-3
1315,BRD-K77771411-003-03-2,imidazoline receptor agonist,H-BIOA-006-3
1316,BRD-K77793136-003-01-4,rho associated kinase inhibitor,H-BIOA-006-3
1317,BRD-K77925998-001-01-3,serotonin receptor agonist,H-BIOA-006-3
1318,BRD-K77947974-001-04-9,dopamine receptor antagonist,H-BIOA-006-3
1319,BRD-K77987382-001-05-8,acetylcholinesterase inhibitor|microtubule inhibitor|tubulin inhibitor,H-BIOA-006-3
1320,BRD-K78010432-001-04-1,diuretic,H-BIOA-006-3
1321,BRD-K78084463-003-01-0,calmodulin antagonist,H-BIOA-006-3
1322,BRD-K78113049-001-04-8,topoisomerase inhibitor,H-BIOA-006-3
1323,BRD-K78122587-300-01-9,T-type calcium channel blocker,H-BIOA-006-3
1324,BRD-K78280988-001-02-2,cannabinoid receptor agonist|potassium channel blocker|TRPV agonist,H-BIOA-006-3
1325,BRD-K78364995-236-03-5,bacterial cell wall synthesis inhibitor,H-BIOA-007-3
1326,BRD-K78485176-001-02-9,angiotensin receptor antagonist,H-BIOA-007-3
1327,BRD-K78599730-001-02-6,farnesyltransferase inhibitor|NFkB pathway inhibitor|ras farnesyltransferase inhibitor,H-BIOA-007-3
1328,BRD-K78633253-001-01-2,ARF inhibitor,H-BIOA-007-3
1329,BRD-K78637815-001-01-4,cannabinoid receptor antagonist,H-BIOA-007-3
1330,BRD-K78643075-001-03-3,dopamine receptor antagonist,H-BIOA-007-3
1331,BRD-K78692225-001-11-2,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,H-BIOA-007-3
1332,BRD-K78815826-001-04-7,cyclooxygenase inhibitor,H-BIOA-007-3
1333,BRD-K78838262-001-02-4,hypolipidemic,H-BIOA-007-3
1334,BRD-K78959463-001-02-5,calcium channel activator,H-BIOA-007-3
1335,BRD-K79092138-001-04-5,POXB inhibitor|bacterial DNA inhibitor,H-BIOA-007-3
1336,BRD-K79116891-003-03-7,sodium channel blocker,H-BIOA-007-3
1337,BRD-K79124250-001-03-0,radiopaque medium,H-BIOA-007-3
1338,BRD-K79131256-001-03-9,tubulin polymerization inhibitor,H-BIOA-007-3
1339,BRD-K79145749-001-01-8,norepinephrine reputake inhibitor,H-BIOA-007-3
1340,BRD-K79366068-236-01-5,NTPDase inhibitor,H-BIOA-007-3
1341,BRD-K79425933-001-03-6,dopamine receptor antagonist,H-BIOA-007-3
1342,BRD-K79437791-001-02-4,Inhibitor of methylation of endogenous isoprenylated proteins,H-BIOA-007-3
1343,BRD-K79501723-003-03-4,histamine receptor modulator,H-BIOA-007-3
1344,BRD-K79684402-300-01-0,dopamine receptor partial agonist,H-BIOA-007-3
1345,BRD-K79711234-001-04-3,bacterial 50S ribosomal subunit inhibitor,H-BIOA-007-3
1346,BRD-K79759585-001-02-1,phosphodiesterase inhibitor,H-BIOA-007-3
1347,BRD-K79930101-300-01-1,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|ErbB2 tyrosine kinase inhibitor|receptor tyrosine protein kinase inhibitor,H-BIOA-007-3
1348,BRD-K80315159-051-01-2,histamine receptor antagonist,H-BIOA-007-3
1349,BRD-K80334323-001-03-5,progestogen hormone,H-BIOA-007-3
1350,BRD-K80353807-001-03-0,vasodilator,H-BIOA-007-3
1351,BRD-K80396088-001-03-9,Sulfonylurea,H-BIOA-007-3
1352,BRD-K80451230-051-01-8,acetylcholine receptor antagonist,H-BIOA-007-3
1353,BRD-K80639402-003-01-1,serotonin receptor antagonist,H-BIOA-007-3
1354,BRD-K80725821-300-01-1,serotonin receptor antagonist,H-BIOA-007-3
1355,BRD-K80738081-001-06-2,cytochrome P450 inhibitor|SIRT activator,H-BIOA-007-3
1356,BRD-K80778372-001-01-7,GABA benzodiazepine site receptor inverse agonist,H-BIOA-007-3
1357,BRD-K80946661-001-02-8,p53 activator,H-BIOA-007-3
1358,BRD-K80970344-201-02-9,NFkB pathway inhibitor,H-BIOA-007-3
1359,BRD-K81029756-001-02-8,L-type calcium channel blocker|calcium channel antagonist|calcium channel blocker,H-BIOA-007-3
1360,BRD-K81209159-001-02-9,Acetylcholinesterase inhibitor,H-BIOA-007-3
1361,BRD-K81209512-001-01-3,EGFR inhibitor|epidermal growth factor receptor (EGFR) inhibitor|tyrosine kinase inhibitor,H-BIOA-007-3
1362,BRD-K81225797-001-01-5,adenosine receptor antagonist,H-BIOA-007-3
1363,BRD-K81272440-001-02-6,calcium channel blocker,H-BIOA-007-3
1364,BRD-K81376179-001-01-4,FLT3 inhibitor,H-BIOA-007-3
1365,BRD-K81709173-001-03-8,glucocorticoid receptor agonist,H-BIOA-007-3
1366,BRD-K81729199-001-01-0,acetylcholine receptor antagonist,H-BIOA-007-3
1367,BRD-K81839095-001-02-0,Estrogen receptor agonist,H-BIOA-007-3
1368,BRD-K81876028-300-01-2,Serotonin receptor agonist,H-BIOA-007-3
1369,BRD-K82103381-003-03-7,vasodilator,H-BIOA-007-3
1370,BRD-K82255054-001-04-3,GABA receptor agonist,H-BIOA-007-3
1371,BRD-K82484965-003-02-7,dopamine receptor agonist,H-BIOA-007-3
1372,BRD-K82561139-001-01-9,casein kinase inhibitor,H-BIOA-007-3
1373,BRD-K82562631-236-02-0,Cyclooxygenase inhibitor,H-BIOA-007-3
1374,BRD-K82577285-001-01-7,Dopamine receptor agonist,H-BIOA-007-3
1375,BRD-K82731415-001-04-7,CDK inhibitor,H-BIOA-007-3
1376,BRD-K82795137-001-02-3,Histamine receptor antagonist,H-BIOA-007-3
1377,BRD-K82823076-001-01-8,GABA benzodiazepine site receptor inverse agonist,H-BIOA-007-3
1378,BRD-K82846253-001-03-0,Insulin secretagogue,H-BIOA-007-3
1379,BRD-K82865713-001-02-6,cAMP inhibitor,H-BIOA-007-3
1380,BRD-K83023055-001-01-9,Melatonin receptor agonist,H-BIOA-007-3
1381,BRD-K83063356-003-01-7,CC chemokine receptor antagonist|CCR antagonist,H-BIOA-007-3
1382,BRD-K83302049-001-01-6,Histamine receptor antagonist,H-BIOA-007-3
1383,BRD-K83322645-103-01-6,sigma receptor antagonist|sigma receptor ligand,H-BIOA-007-3
1384,BRD-K83459933-001-02-1,angiogenesis inhibitor,H-BIOA-007-3
1385,BRD-K83508485-001-01-9,tachykinin antagonist,H-BIOA-007-3
1386,BRD-K83597974-003-05-7,Monoamine oxidase inhibitor,H-BIOA-007-3
1387,BRD-K83637872-001-01-7,Smoothened receptor antagonist,H-BIOA-007-3
1388,BRD-K84175871-003-02-2,Adrenergic receptor agonist,H-BIOA-007-3
1389,BRD-K84266862-001-01-6,phosphodiesterase inhibitor,H-BIOA-007-3
1390,BRD-K84421793-001-01-1,dopamine receptor agonist,H-BIOA-007-3
1391,BRD-K84595254-001-03-0,ATPase inhibitor,H-BIOA-007-3
1392,BRD-K84663978-001-02-3,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker,H-BIOA-007-3
1393,BRD-K84663978-001-03-1,phosphodiesterase inhibitor|platelet aggregation inhibitor|potassium channel blocker,H-BIOA-007-3
1394,BRD-K84709232-001-02-6,lipoxygenase inhibitor|HIV integrase inhibitor|NFkB pathway inhibitor|nitric oxide production inhibitor|PPAR receptor modulator|tumor necrosis factor production inhibitor,H-BIOA-007-3
1395,BRD-K85015012-003-01-1,GABA uptake inhibitor|GAT inhibitor,H-BIOA-007-3
1396,BRD-K85090592-003-08-7,Acetylcholine receptor agonist,H-BIOA-007-3
1397,BRD-K85119730-001-06-5,ATP channel blocker,H-BIOA-007-3
1398,BRD-K85242180-001-01-1,"indoleamine 2,3-dioxygenase inhibitor",H-BIOA-007-3
1399,BRD-K85266041-304-01-7,glutamate receptor antagonist,H-BIOA-007-3
1400,BRD-K85383046-001-02-5,chloride channel blocker,H-BIOA-007-3
1401,BRD-K85871428-001-01-9,p38 MAPK inhibitor,H-BIOA-007-3
1402,BRD-K85883481-001-02-6,glucocorticoid receptor agonist,H-BIOA-007-3
1403,BRD-K86204871-001-02-2,sterol demethylase inhibitor,H-BIOA-007-3
1404,BRD-K86301799-001-14-0,phosphodiesterase inhibitor,H-BIOA-007-3
1405,BRD-K86434416-001-02-7,Monoamine oxidase inhibitor,H-BIOA-007-3
1406,BRD-K86509404-001-02-0,CDK inhibitor,H-BIOA-007-3
1407,BRD-K86600316-003-01-2,Adrenergic receptor antagonist,H-BIOA-007-3
1408,BRD-K86727142-001-06-6,HCV inhibitor|XIAP inhibitor,H-BIOA-007-3
1409,BRD-K86873305-236-03-0,Bacterial cell wall synthesis inhibitor,H-BIOA-007-3
1410,BRD-K86882815-001-01-6,dopamine receptor agonist|prolactin inhibitor|prolactin secretion inhibitor,H-BIOA-007-3
1411,BRD-K86958018-001-01-9,TRPV agonist,H-BIOA-007-3
1412,BRD-K87048468-003-01-9,Serotonin receptor antagonist,H-BIOA-007-3
1413,BRD-K87049188-001-03-6,chelating agent|dopamine beta hydroxylase inhibitor,H-BIOA-007-3
1414,BRD-K87510569-001-01-0,CC chemokine receptor antagonist,H-BIOA-007-3
1415,BRD-K87696786-003-01-0,glutamate receptor antagonist,H-BIOA-007-3
1416,BRD-K87990216-001-03-7,Glucocorticoid receptor agonist,H-BIOA-007-3
1417,BRD-K87991767-001-02-0,carbonic anhydrase inhibitor|cyclooxygenase inhibitor,H-BIOA-007-3
1418,BRD-K88090157-050-03-3,antihistamine,H-BIOA-007-3
1419,BRD-K88282786-066-04-9,cannabinoid receptor agonist,H-BIOA-007-3
1420,BRD-K88358234-003-01-4,serotonin receptor agonist|nerve growth factor agonist|neurotrophic factor enhancer,H-BIOA-007-3
1421,BRD-K88366685-300-03-7,3-ketoacyl CoA thiolase inhibitor,H-BIOA-007-3
1422,BRD-K88405679-003-01-5,antihistamine,H-BIOA-007-3
1423,BRD-K88429204-001-04-7,dihydrofolate reductase inhibitor,H-BIOA-007-3
1424,BRD-K88544581-001-01-2,ACAT inhibitor,H-BIOA-007-3
1425,BRD-K88568253-065-02-1,monoamine oxidase inhibitor,H-BIOA-007-3
1426,BRD-K88611939-001-01-8,Glutamate receptor agonist,H-BIOA-007-3
1427,BRD-K88677950-001-01-3,MAP kinase inhibitor|MEK inhibitor,H-BIOA-007-3
1428,BRD-K88741031-001-01-0,EGFR inhibitor|tyrosine kinase inhibitor,H-BIOA-007-3
1429,BRD-K88743730-001-01-0,serotonin receptor partial agonist,H-BIOA-007-3
1430,BRD-K88759641-003-01-0,Angiotensin receptor antagonist,H-BIOA-007-3
1431,BRD-K88789588-001-03-2,aromatase inhibitor,H-BIOA-007-3
1432,BRD-K88809146-003-02-1,monoamine oxidase inhibitor,H-BIOA-007-3
1433,BRD-K88849294-001-02-1,Tyrosine phosphatase inhibitor,H-BIOA-007-3
1434,BRD-K88871508-001-01-9,Dopamine receptor agonist,H-BIOA-007-3
1435,BRD-K89046952-001-03-4,bacterial cell wall synthesis inhibitor,H-BIOA-007-3
1436,BRD-K89055274-048-03-7,muscle relaxant,H-BIOA-007-3
1437,BRD-K89085489-001-02-6,apoptosis stimulant|retinoid receptor agonist,H-BIOA-007-3
1438,BRD-K89125793-001-05-4,antiprotozoal agent,H-BIOA-007-3
1439,BRD-K89152108-001-03-3,thyroid hormone stimulant,H-BIOA-007-3
1440,BRD-K89210380-001-03-8,vitamin B,H-BIOA-007-3
1441,BRD-K89272762-001-04-4,chloride channel blocker,H-BIOA-007-3
1442,BRD-K89274813-001-01-5,acetylcholine release enhancer,H-BIOA-007-3
1443,BRD-K89375097-300-04-7,Acetylcholine receptor antagonist,H-BIOA-007-3
1444,BRD-K89402695-001-01-5,Thromboxane receptor antagonist,H-BIOA-007-3
1445,BRD-K89732114-001-02-6,dopamine receptor antagonist,H-BIOA-007-3
1446,BRD-K89923877-003-02-4,acetylcholine receptor antagonist,H-BIOA-007-3
1447,BRD-K89930444-001-01-9,tyrosine kinase inhibitor,H-BIOA-007-3
1448,BRD-K89997465-001-02-0,dopamine receptor antagonist,H-BIOA-007-3
1449,BRD-K90027355-001-03-4,mineralocorticoid receptor antagonist,H-BIOA-007-3
1450,BRD-K90259198-003-04-8,calmodulin antagonist|potassium channel blocker|squalene monooxygenase channel blocker,H-BIOA-007-3
1451,BRD-K90333595-001-02-8,adrenergic receptor antagonist,H-BIOA-007-3
1452,BRD-K90382497-001-01-6,PLK inhibitor,H-BIOA-006-3
1453,BRD-K90524085-001-05-2,phosphodiesterase inhibitor|platelet aggregation inhibitor,H-BIOA-007-3
1454,BRD-K90574421-001-01-9,Serotonin receptor agonist,H-BIOA-007-3
1455,BRD-K90789829-003-03-3,Adrenergic inhibitor,H-BIOA-007-3
1456,BRD-K90976994-001-02-1,Bile acid,H-BIOA-007-3
1457,BRD-K91243525-001-01-5,Neurotensin receptor antagonist,H-BIOA-007-3
1458,BRD-K91263825-001-02-8,tricyclic antidepressant,H-BIOA-007-3
1459,BRD-K91315211-334-02-3,Histamine receptor agonist,H-BIOA-007-3
1460,BRD-K91336023-001-01-4,Dopamine receptor agonist,H-BIOA-007-3
1461,BRD-K91370081-001-04-6,DNA synthesis inhibitor,H-BIOA-007-3
1462,BRD-K91904471-001-01-6,p38 MAPK inhibitor,H-BIOA-007-3
1463,BRD-K92000912-001-06-8,cannabinoid receptor antagonist,H-BIOA-007-3
1464,BRD-K92015269-001-01-6,dopamine uptake inhibitor,H-BIOA-007-3
1465,BRD-K92049597-001-04-2,sodium channel blocker,H-BIOA-007-3
1466,BRD-K92093830-003-05-0,topoisomerase inhibitor,H-BIOA-007-3
1467,BRD-K92138166-001-01-0,other antibiotic,H-BIOA-007-3
1468,BRD-K92492521-001-01-1,Leukotriene receptor antagonist,H-BIOA-007-3
1469,BRD-K92678294-001-01-0,Isoflavone,H-BIOA-007-3
1470,BRD-K92723993-066-02-9,PDGFR tyrosine kinase receptor inhibitor|Bcr-Abl kinase inhibitor|KIT inhibitor|Abl kinase inhibitor|apoptosis stimulant|breast cancer resistance protein inhibitor|colony stimulating factor receptor inhibitor,H-BIOA-006-3
1471,BRD-K92726801-003-02-7,Haemostatic agent,H-BIOA-007-3
1472,BRD-K92731339-227-02-3,ACE inhibitor,H-BIOA-007-3
1473,BRD-K92758126-001-06-3,NFkB pathway inhibitor,H-BIOA-007-3
1474,BRD-K92778217-001-04-6,Cyclooxygenase inhibitor,H-BIOA-007-3
1475,BRD-K92830582-003-04-8,adrenergic receptor antagonist,H-BIOA-007-3
1476,BRD-K92984783-003-02-4,Serotonin receptor antagonist,H-BIOA-007-3
1477,BRD-K93080877-001-02-1,tripeptidyl peptidase inhibitor,H-BIOA-007-3
1478,BRD-K93176058-001-01-0,retinoid receptor agonist,H-BIOA-007-3
1479,BRD-K93188295-300-01-4,adrenergic receptor antagonist,H-BIOA-007-3
1480,BRD-K93201660-001-05-7,myosin light chain kinase inhibitor,H-BIOA-006-3
1481,BRD-K93258693-001-02-5,PPAR receptor antagonist,H-BIOA-007-3
1482,BRD-K93280214-004-02-3,GABA receptor antagonist,H-BIOA-007-3
1483,BRD-K93325701-001-03-0,SRC inhibitor,H-BIOA-007-3
1484,BRD-K93332168-001-03-2,Monoamine oxidase inhibitor,H-BIOA-007-3
1485,BRD-K93441486-067-03-7,Acetylcholine receptor antagonist,H-BIOA-007-3
1486,BRD-K93460210-001-01-3,Serotonin receptor antagonist,H-BIOA-007-3
1487,BRD-K93461745-001-01-5,Serotonin receptor agonist,H-BIOA-007-3
1488,BRD-K93480852-001-02-2,calcium/calmodulin dependent protein kinase inhibitor,H-BIOA-007-3
1489,BRD-K93568044-001-03-1,glucocorticoid receptor agonist,H-BIOA-007-3
1490,BRD-K93658967-001-01-7,CDK inhibitor|CFTR channel activator|glycogen synthase kinase inhibitor|JNK inhibitor,H-BIOA-007-3
1491,BRD-K93754473-001-02-9,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),H-BIOA-007-3
1492,BRD-K94144010-001-05-5,nicotine metabolite,H-BIOA-007-3
1493,BRD-K94270326-004-01-0,dopamine receptor antagonist,H-BIOA-007-3
1494,BRD-K94379058-001-03-5,cannabinoid receptor inverse agonist,H-BIOA-007-3
1495,BRD-K94441233-001-03-1,HMGCR inhibitor,H-BIOA-007-3
1496,BRD-K94512704-001-01-3,dopamine receptor antagonist,H-BIOA-007-3
1497,BRD-K94689771-001-02-5,CYP1B1 inhibitor,H-BIOA-007-3
1498,BRD-K94832621-001-01-5,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),H-BIOA-007-3
1499,BRD-K94841585-001-02-8,laxative|free radical generator,H-BIOA-007-3
1500,BRD-K94887716-001-01-5,Serotonin receptor agonist,H-BIOA-007-3
1501,BRD-K94920105-001-01-3,PARP inhibitor,H-BIOA-007-3
1502,BRD-K95202259-001-01-9,p38 MAPK inhibitor,H-BIOA-007-3
1503,BRD-K95237249-001-04-2,Uricosuric blocker,H-BIOA-007-3
1504,BRD-K95309561-001-04-9,estrogen receptor agonist,H-BIOA-007-3
1505,BRD-K95435023-001-01-0,c-Met inhibitor|hepatocyte growth factor receptor inhibitor,H-BIOA-007-3
1506,BRD-K95603879-001-03-4,ATPase inhibitor,H-BIOA-007-3
1507,BRD-K95609758-001-01-1,potassium channel activator,H-BIOA-007-3
1508,BRD-K95655893-001-01-0,VEGFR kinase inhibitor,H-BIOA-007-3
1509,BRD-K95676198-001-02-6,JAK inhibitor,H-BIOA-007-3
1510,BRD-K95739795-001-01-1,Vesicular monoamine transporter inhibitor,H-BIOA-007-3
1511,BRD-K95763993-001-03-7,PDGFR receptor inhibitor,H-BIOA-007-3
1512,BRD-K95785537-001-04-1,src inhibitor,H-BIOA-007-3
1513,BRD-K95851186-001-02-9,GABA receptor modulator,H-BIOA-007-3
1514,BRD-K95899059-003-01-0,Serotonin receptor agonist,H-BIOA-007-3
1515,BRD-K95992530-001-02-4,integrin antagonist,H-BIOA-007-3
1516,BRD-K96119599-001-04-7,Melanin inhibitor,H-BIOA-007-3
1517,BRD-K96144918-001-02-3,KPL-1 tumor suppressor,H-BIOA-007-3
1518,BRD-K96263742-001-02-3,PPAR receptor agonist,H-BIOA-007-3
1519,BRD-K96271548-001-02-2,antioxidant,H-BIOA-007-3
1520,BRD-K96402602-001-01-8,PPMTase inhibitor,H-BIOA-007-3
1521,BRD-K96527333-001-03-4,GABA receptor modulator,H-BIOA-007-3
1522,BRD-K96670504-001-01-9,Glucokinase inhibitor,H-BIOA-007-3
1523,BRD-K96720755-001-01-8,Vasopressin receptor antagonist,H-BIOA-007-3
1524,BRD-K96799727-001-01-7,HSP inhibitor,H-BIOA-007-3
1525,BRD-K96809896-001-01-9,p38 MAPK inhibitor,H-BIOA-007-3
1526,BRD-K96862998-001-03-1,TGF beta receptor inhibitor,H-BIOA-007-3
1527,BRD-K97061094-001-03-2,Histamine receptor antagonist,H-BIOA-007-3
1528,BRD-K97118047-001-01-2,Casein kinase inhibitor,H-BIOA-007-3
1529,BRD-K97158071-001-04-1,Dopamine receptor antagonist,H-BIOA-007-3
1530,BRD-K97181089-001-02-7,sodium channel blocker,H-BIOA-007-3
1531,BRD-K97330509-001-01-4,src inhibitor,H-BIOA-007-3
1532,BRD-K97354755-001-01-5,src inhibitor,H-BIOA-007-3
1533,BRD-K97365803-001-01-3,PI3K inhibitor,H-BIOA-007-3
1534,BRD-K97399794-001-07-0,polar auxin transport inhibitor,H-BIOA-007-3
1535,BRD-K97440753-066-03-3,adrenergic receptor antagonist|prolactin inhibitor,H-BIOA-007-3
1536,BRD-K97509413-001-01-8,AGE inhibitor|estrogen receptor agonist|estrogen receptor ligand,H-BIOA-007-3
1537,BRD-K97521363-001-03-9,glycolysis inhibitor,H-BIOA-007-3
1538,BRD-K97530723-001-04-3,melatonin receptor agonist|nitric oxide synthase inhibitor,H-BIOA-007-3
1539,BRD-K97564742-103-01-9,histamine receptor antagonist,H-BIOA-007-3
1540,BRD-K97688263-001-02-9,sodium channel blocker,H-BIOA-007-3
1541,BRD-K97746869-001-04-9,ATP channel blocker,H-BIOA-007-3
1542,BRD-K97752965-001-01-6,ATP channel activator|nitric oxide donor|potassium channel agonist,H-BIOA-007-3
1543,BRD-K97799481-002-03-6,Adenosine receptor antagonist,H-BIOA-007-3
1544,BRD-K97810537-001-03-7,glucocorticoid receptor agonist,H-BIOA-007-3
1545,BRD-K98039984-001-03-0,glucocorticoid receptor agonist,H-BIOA-007-3
1546,BRD-K98143437-001-01-7,p38 MAPK inhibitor|interleukin inhibitor|tumor necrosis factor production inhibitor,H-BIOA-007-3
1547,BRD-K98157055-001-04-2,glutamate receptor antagonist,H-BIOA-007-3
1548,BRD-K98174813-001-05-7,bacterial 30S ribosomal subunit inhibitor,H-BIOA-007-3
1549,BRD-K98297262-001-01-1,"1,3-beta-glucan synthase inhibitor",H-BIOA-007-3
1550,BRD-K98521173-001-03-8,mineralocorticoid receptor agonist,H-BIOA-007-3
